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ABSTRACT 
SUPRAMOLECULAR STRATEGIES FOR THE GENERATION OF 
NANOPARTICLE ASSEMBLIES AND BIOMOLECULAR THIN FILMS 
FEBRUARY 2016 
BRADLEY P. DUNCAN, H.A.B., SAINT ANSELM COLLEGE 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Vincent M. Rotello 
The conceptual framework of supramolecular chemistry elucidates a powerful set 
of strategies for chemists to generate functional nanomaterials based on intermolecular 
forces.  My research focused on tuning the molecular interactions of nanoscale 
components to create larger structures with enhanced properties.  In one approach, I 
developed and optimized an additive-free, nanoimprint lithography-based methodology 
to generate stable thin films from a variety of proteins.  The generalized process retains 
intrinsic properties of the protein as demonstrated by selective cellular adhesion.  The 
heat and pressure of the nanoimprinting process induces slight structural reorganization 
of the peptide side chains to yield highly stable films held together by inter-protein 
hydrophobic forces.  The selective cell adhesion shown by our initial model proteins was 
further harnessed using inkjet printing to control the micropatterning of biomaterial 
substrates in a highly modular fashion.  The protein-based ‘ink’ deposition when 
combined with the nanoimprint lithography stabilization procedure permits the rapid 
creation of patterns and film compositions not achievable using other nanomanufacturing 
techniques.  My research also demonstrates that the supramolecular interactions that 
 viii 
 
occur at the surface of nanomaterials can be used to create complexes to interact with the 
human olfactory system.  Surface functionalized gold nanoparticles serve as selective and 
reversible inhibitors for enzymes that upon displacement by analytes in solution generate 
a scent-based signal from pro-fragrance molecules.  The self-assembly of nanoparticles at 
oil/water interfaces led to the development of an alternative method to form nanoparticle-
polymer nanocomposites.  The assembled composite system, generated by crosslinking 
and phase transferring hydrophilic nanoparticles into the hydrophobic oil core, showed 
remarkable stability to the phase disrupting influence of ethanol.   This inside-out 
Pickering emulsion template later aided in the creation of a multimodal nanoparticle 
stabilized capsule platform for the treatment of bacterial biofilms.  The amine surface 
functionality of the nanoparticles both improved delivery to bacterial biofilms through 
complementary electrostatic interactions as well as stabilized the therapeutic payload of 
the capsules through the formation of Schiff bases.  Overall, these examples highlight the 
potency of using supramolecular strategies for the intelligent design of nanomaterials.  
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CHAPTER 1 
ASSEMBLING FUNCTIONAL NANOMATERIALS 
 1.1. Overview of Nanoscale Materials 
Nanomaterials are defined as objects that possess a component with at least one 
dimension in the nanometer length scale.  These nanoscale materials are particularly 
attractive since they display unique physiochemical properties not achievable with bulk 
material analogues.1  Examples of commonly used nanoscale materials are shown in 
Figure 1.1.  The large surface area to volume ratios possessed by nanomaterials make 
them advantageous materials for catalytic,2 therapeutic,3 sensing,4 and electronic 
applications.5  Furthermore, the biologically relevant scale of nanomaterials can be 
employed to interface and interact many biological structures, such as cell membranes 
and proteins, to provide unique insight into the underlying behaviors.6  The following 
chapter will focus on the materials and methods that served as the background for this 
thesis. 
 
Figure 1.1: A space filling model of bovine serum albumin, a scanning electron 
micrograph of silica nanoparticles, and a thin protein film on a silica wafer are shown as 
representative nanomaterials. 
 2 
 
1.1.1. Proteins 
Proteins provide a naturally occurring nanoscale building material.  Most proteins 
are constructed using 100-500 of amino acid building blocks or residues.  The individual 
amino acids possess side chains of varying functionality.  These groups give the amino 
acids their unique chemical properties.  The order in which the amino acids are 
sequentially arranged is described as the primary structure of the protein.  Dependent on 
this ordering of the side chains, segments of the polymer assemble into various structures 
due to van der Waals, hydrogen bonding, electrostatic, hydrophobic, and disulfide 
crosslinking interactions.  These individual secondary structures of the protein, such as 
alpha helices and beta-sheets, are further assembled into a tertiary structure that gives the 
protein an overall structural character such as globular, fibrous, or random coil.  Their 
inherent structure and functionality allows their rapid incorporation into functional 
materials.   
Proteins serve a variety of biological functions including cell signaling, enzymatic 
catalysis, and structural support of tissues.  The behavior of the protein is dependent on 
its tertiary structure.  Proteins can be divided into 3 main classes: globular, fibrous, and 
membrane proteins which correlates with their tertiary structures.  Globular proteins are 
primarily water soluble, generally spherical in three dimensional shape, and can be 
transporter proteins as well as enzymes.  Fibrous proteins are structural 
biomacromolecules that assemble to form connective tissues which are water insoluble.  
Membrane proteins interact with biological membranes such as the cell’s phospholipid 
bilayer to aid in cellular response to environmental stimuli.    
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1.1.2. Nanoparticles 
Nanoparticles possess unique physiochemical properties compared to bulk 
materials.7  These size dependent characteristics of nanomaterials, as shown in Table 1.1, 
give rise to a variety of phenomenon such as quantum confinement of photons,8 enhanced 
permeation and retention within cancerous tissues,9 and superparamagnetic behavior of 
transition metals.10  Furthermore, the behavior of nanoparticles depends greatly on the 
surface functionalization of the nanoparticle.11  The chemical moieties present at the 
surface of nanoparticles can be tailored to regulate biological processes, such as 
exocytosis, as demonstrated by the work of Rotello et al.12  Additionally, Mirkin and 
coworkers have shown that DNA functionalized nanoparticles can be “crystallized” into 
larger assemblies through rational design rules of the surface chemistry of the individual 
nanoparticles.13   
Table 1.1: Metal and semiconductor nanoparticles commonly used for biological 
applications and their corresponding properties.  Reprinted from Ref. 7 with 
permission from Wiley‐VCH Verlag GmbH & Co. 
 
Core 
material 
Characteristics Ligand(s) Applications 
Au 
Optical absorption, 
fluorescence and fluorescence 
quenching, stability 
Thiol, disulfide, 
phosphine, amine 
Biomolecular 
recognition, delivery, 
sensing 
Ag Surface-enhanced fluorescence Thiol Sensing 
Pt Catalytic property 
Thiol, phosphine, 
amine, isocyanide 
Bio-catalyst, sensing 
CdSe Luminescence, photo-stability 
Thiol, phosphine, 
pyridine 
Imaging, sensing 
Fe2O3 Magnetic property 
Diol, dopamine 
derivative, amine 
MR imaging and 
biomolecule 
purification 
SiO2 Biocompatibility Alkoxysilane 
Biocompatible by 
surface coating 
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1.1.3. Thin Films 
Thin films of polymeric materials have been used for a variety of applications 
such as antifouling coatings,14 photovoltaics,15 and biosensors.16  These films offer a 
tailorable interface to alter the functional, mechanical, and biological behavior of 
substrates in a modular fashion.17  As demonstrated in Figure 1.2, a thin film can be held 
together by a variety of supramolecular forces between the individual components 
comprising the film.18  In addition, the layers of materials assembled on surfaces often 
vastly alters the properties of the underlying substrate.19  The chemical structure of the 
layer material, method used for coating the underlying substrate, and post-
functionalization can all be used to modify the final behavior of the thin film.20 
 
Figure 1.2: Schematic depiction of methods used to form Layer-by-Layer (LbL) films.  
Supramolecular interactions between the polymers within the film affect the behavior of 
the overall device.   Spray-LbL is an example of rapid method to deposit these films on 
medical devices.  Reprinted from Ref. 18 with permission from Wiley‐VCH Verlag 
GmbH & Co.   
Thin films are particular attractive scaffolds for creating biomaterial coatings.  For 
instance, the surface functionality of thin films has been shown to modulate immune 
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response,21 protein adsorption,22 and affect cellular adhesion/behavior.23  
Biodegradability can also be tuned to create controlled release drug platforms.24  For 
example, Hammond et al. demonstrated that thin polymer coatings on bone implants that 
contain osteoconductive hydroxyapatite and osteoinductive recombinant human bone 
morphogenetic protein-2 effectively induced integration of the implant into the host 
tissue.25   Overall, the surface functionalities of the components of the thin film tend to 
dictate the performance of the film.  Therefore, expanding the range of incorporable, 
biocompatible polymers to form stable films would greatly improve the field. 
1.2. Nanoscale Fabrication Techniques 
The two basic methodologies for the generation of nanomaterials can be classified 
as either “bottom-up” or “top-down” approaches.26  Bottom-up approaches rely on the 
spontaneous assembly of smaller components into larger materials dependent on the 
interactions between the individual constituents.  Top-down methods, on the other hand, 
reduce larger substrates into smaller units via etching, milling, or other physical removal 
of surface elements from the initial material.  As shown in Figure 1.3, both of these 
strategies can be used to generate similar structures albeit via diametrically opposed 
pathways.  Bottom-up assemblies generate feature sizes that cannot be created following 
a top-down approach.  Structures that are formed from top-down approaches can be 
achieved on much larger substrates and more rapidly than bottom-up approaches can 
produce.  
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Figure 1.3: Analogies for the production of a statue via bottom-up and top-down 
fabrication methods: a) Lego pieces can be connected to build a sculpture in a similar 
fashion that surfactant molecules can self-assemble into micellar structures.  b) Marble is 
sculpted from a larger block to reveal the stone statue within in much the same way that 
an AFM tip can be used to carve patterns into silicon substrates.  Reprinted from Ref. 26 
with permission from the RSC. 
 
1.2.1. Bottom-up Assembly 
Bottom-up assembly employs small building blocks that self-organize into larger 
structures.  For example, DNA origami nanodevices,27 liposomes,28 and metal-organic 
frameworks29 are widely used nanomaterials that depend on combining individual 
components to create synergistic constructs.  These assemblies are held together by non-
covalent interactions, such as Van der Waals forces, hydrogen bonding, metal 
coordination, and electrostatic interactions.30  The non-covalent nature of these 
interactions give rise to a variety of dynamic assemblies.  In particular, the protean 
surface chemistry of nanomaterials offers a versatile palette to subtly influence biological 
behaviors at the molecular level.31   
Rotello et al. have developed a variety of sensors based on the selective 
interactions of surface functionalized gold nanoparticles with biological systems.32,33  An 
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unbiased sensor array based on the electrostatic interactions between an anionic 
fluorescent probe and multiple cationic functionalized gold nanoparticles was developed 
initially for cancer cell sensing.  Complexation with the nanoparticle reversibly quenches 
the fluorescence of the probe.  Following incubation with cells in a 96 well plate, the 
fluorescence of the probe is regenerated due to competitive binding for the nanoparticle 
surface (Figure 1.4).  This selective response can also be used to differentiate bacteria and 
bacterial biofilms indicating the generality of this sensing strategy across biological 
systems.34,35  These cationic gold nanoparticles have also been shown to reversibly 
control the catalytic activity of the enzyme β-galactosidase.36  The complementary 
electrostatic interactions between the anionic β-galactosidase and the cationic 
nanoparticles is disrupted in the presence of bacteria generating an enzymatically 
amplified signal.37  
 
Figure 1.4: Sensor array formed through the self-assembly gold nanoparticles and 
fluorescent probes.  Sample differentiation and classification is accomplished by 
combining the individual responses from wells each containing differently functionalized 
nanoparticles and performing statistical analysis to the data.  Reprinted from Ref. 38 with 
permission from Elsevier. 
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1.2.2. Top-down Assembly 
Top-down assembly strategies rely on taking a larger substrate and dividing it into 
smaller pieces.  The smaller components are made through the slicing, etching, or cutting 
of the raw material.  Common top-down nanomanufacturing approaches are inkjet 
printing,39 photolithography,40 dip-pen nanolithography,41 and nanoimprint lithography.42  
The processing steps transfer a ‘master’ pattern unto the substrate generating the final 
structure.  The attainable feature sizes and complexities of the patterns is dependent on 
the resolution of the manufacturing technique used. 
Nanoimprint lithography is a particularly promising technique due to its low cost, 
simplicity, and high-throughput potential.43  The process, as shown in Figure 1.5, is 
accomplished by physically deforming a thin polymer film with a patterned mask under 
high temperature and pressure.44  The polymer film is reorganized to replicate the 
nanometer sized features of the mask.  The transferred patterned polymer film can be 
used for a range of fields such as controlled cellular behavior,45 photonics,46 and 
magneto-optics.47   
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Figure 1.5: Schematic of the NIL process.  Reprinted from Ref. 44 with permission from 
Wiley‐VCH Verlag GmbH & Co. 
 
1.3. Protein Film Based Materials 
Thin films of proteins are often fabricated through the self-assembly or 
crosslinking of individual protein molecules.  Protein films are widely used in a variety of 
applications such as artificial organs,48 drug-releasing patches,49 and food packaging.50  
Proteins that self-assemble in nature (e.g. amyloidogenic,51 silk proteins,52 collagen,53 and 
fibrinogen54) provide particularly attractive scaffolds, combining biodegradability and 
biocompatibility in materials comprised entirely of natural precursors.  The remarkable 
stability of these proteins is generally attributed to β-sheet rich regions in the peptide 
backbone that aggregate to form the resultant film.  These attributes have made these 
protein-based materials especially promising materials for interfacing with cells for tissue 
engineering55 and wound healing56 applications.  Soy protein scaffolds have been used 
for tissue regeneration,57 collagen-based scaffolds have been employed for culturing 
retinal epithelial cells,58 and both collagen and chitosan-gelatin scaffolds have been used 
for making artificial skin.59 Amyloid-forming proteins likewise provide a useful 
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platform.60 For example, Welland’s group demonstrated a scalable self-assembly 
approach to make free-standing films from amyloid protein fibrils.51  Langer et al. have 
fabricated micropatterned cellular co-cultures by using layer-by-layer deposition of 
hyaluronic acid and fibronectin (Figure 1.6). This co-culture system allowed researchers 
to study complicated cell behaviors, including cell-cell communication.61  
 
Figure 1.6: a) Co-culture systems were fabricated using capillary force lithography 
followed by the layer-by-layer deposition of hyaluronic acid and fibronectin. b) Cells 
were fluorescently stained, AML 12 (green) and NIH-3T3 (red), to show the spatial 
distribution of each cell type.  Reprinted from Ref. 61 with permission from Elsevier. 
Outside the small number of self-assembling proteins, most proteins generate 
films that are not stable under aqueous conditions severely limiting their potential 
biomaterial applications.62  One strategy to improve the stability of protein films is to use 
covalent crosslinkers,63 including glutaraldehyde,64 formaldehyde,65 and glyoxal.66  
However, these treatments can compromise the behavior of the films, and residual free 
linkers or those released from the hydrolysis of film can cause toxic effects.67 
Alternatively, side chain modification can be used to impart stability to protein films.68 
As shown in Figure 1.7, Chen’s group demonstrated that soy proteins modified with 
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diethoxyphosphoryl groups feature enhanced film stability.  UV crosslinking can also be 
used to stabilize films, though the irreversible chemical modification to the protein that 
will occur using this process limits the biocompatibility of the film.69  
 
Figure 1.7:  Photographs demonstrating the stability of the native soy protein film a), at 
50 % humidity and b) in the wet state.  Photographs demonstrating the stability of the 
chemical modified soy protein film c), at 50 % humidity and d) in the wet state.  
Reprinted from Ref. 68 with permission from the RSC. 
Heat curing of proteins is a straightforward technique to generate water-stable 
films.70  Many approaches have used elevated temperatures to form soy,71 amaranth,72 
and whey protein73 films.  However, the temperature of the treatment greatly affects the 
stability of the protein film, and can lead to unwanted chemical reactions such as the 
Maillard reaction.74  In addition, heat curing often results in significantly denatured 
protein films.75  Therefore, the development of new methods that could incorporate a 
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broader set of proteins, without compromising the structural integrity of the protein, 
would vastly expand the biomaterial potential of films comprised solely of proteins. 
1.4. Colloidal Assembly at Liquid/Liquid Interfaces 
The boundary between two different phases is a thermodynamically constrained 
condition.  This unstable interface will reorganize the interacting molecules in order to 
achieve a lower energetic state.  Colloidal particles localize at these interfaces, such as 
between immiscible liquids, to minimize the free energy of overall system. (Figure 1.8a)  
This phenomenon was first observed by Ramsden76 and Pickering77 at the turn of the 20th 
century and the structures were then identified as “Pickering emulsions.”  This bottom-up 
assembly strategy has been used to create a variety of stable structures such as catalysts,78 
drug delivery vehicles,79 and microreactors.80  Pieranski demonstrated that this observed 
stability due to the decreased interfacial energy could be explained with the following 
equation:81 
∆𝐸 = 𝜋𝑟2𝛾𝑜
𝑤⁄
× (1 − cos 𝜃)2 
The major factors in Equation 1 that contribute to minimizing the interfacial 
energy of colloidal interfaces are the effective radius of the particle (r), the surface 
tension between the oil and water phases (γo/w), and the wettability of the particle surface 
(i.e. contact angle θ of the particle at interface as shown in Figure 1.8b).   The greater the 
diameter of particle used to stabilize the interface, more likely the particle is to resist 
displacement by thermal fluctuations in the system.  This behavior is due to the greater 
amount of work required to remove a larger particle from the interface and disperse it 
into the mother liquor than is required for a smaller particle.   Adjusting the wettability of 
the particle through surface functionalization and modification to generate more 
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amphiphilic particles, ideally a contact angle θ = 90°, can also be used to further improve 
the stability of the emulsion.82   Typically, hydrophilic NPs stabilize oil-in-water 
emulsions and hydrophobic NPs are used to stabilize water-in-oil emulsions.   
 
Figure 1.8: Schematic illustration of Pickering emulsions.  a) Particles self-assemble at 
the oil/water interface to form stable emulsions.  b)  Isotropic particle present at the 
oil/water interface.    
  
1.5. Dissertation Overview 
The research described herein will focus on tuning of the molecular interactions 
of nanoscale building blocks to create highly versatile systems.  Chapter 2 describes the 
development of a generalized protein film stabilization strategy using nanoimprint 
lithography.  Both processing conditions used during fabrication as well as the structure 
of the protein precursor were shown to influence the stability and cytophilicity of the 
resultant films.  Chapter 3 expands on the selective mammalian cell adhesion 
demonstrated by films of the individual proteins by introducing a modular inkjet printing 
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deposition technique to generate tunable biomaterial surfaces.  Chapter 4 describes the 
development of a supramolecular construct to enhance the human olfactory system 
beyond our antediluvian limitations.  Chapter 5 provides a Pickering emulsion based 
method to create discrete inorganic-organic microparticles for the retention of 
hydrophobic payloads.  Finally, Chapter 6 discusses the generation of a nanoparticle-
stabilized capsule based assembly for treatment of bacterial biofilms. 
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CHAPTER 2 
ROBUST PROTEIN FILMS GENERATED VIA NANOIMPRINT 
LITHOGRAPHY 
2.1. Introduction  
Protein-based materials provide a uniquely biocompatible and sustainable 
platform for the generation of functional materials.1,2,3,4  The intrinsic structural and 
functional diversity inherent to proteins make them highly versatile building blocks.5  
Prior research has harnessed the innate biocompatibility of protein films for applications 
as diverse as bioelectronics,14 tissue engineering,10,11,16 and drug delivery.13,15  Proteins 
also possess aqueous processability6 and have minimal environmental impact,7 making 
them ideal components for sustainable "green" materials.  Translating these 
characteristics into protein films resistant to aqueous degradation is crucial for most 
applications such as tissue engineering and controlled drug delivery.8,9,10,11,12  
Current methods to stabilize protein films use two main strategies: employing a 
relatively limited range of naturally self-assembling proteins2,3,4 or using added 
crosslinkers.13,14,15,16,17  Naturally-assembling proteins, such as silk fibroin, can be 
processed into a multitude of biocompatible structures, though post-functionalization is 
often needed to diversify the surface chemistry of the films.18  The latter covalent 
crosslinking strategy generates polymeric complexes from a variety of proteins, however, 
unreacted additives retained in the crosslinked protein films can adversely affect their 
final behavior.18,19,20,21  Therefore an alternative methodology to stabilize protein films 
would vastly expand the functional toolkit for creating biomaterials. 
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We demonstrate here a scalable, additive-free nanoimprint lithography (NIL) 
based method for the fabrication of stable, patterned protein films.  This approach is 
general in terms of protein building block, with the imprinted proteins retaining much of 
their native structure and hence materials properties.  The surface charge of the films can 
be programmed through choice of protein, as demonstrated though Kelvin probe force 
microscopy.  Simultaneously, the stability and degradability of these materials is 
controlled through parametric variation of processing temperature and pressure.  The 
ability to utilize these materials properties is highlighted through generation of effective 
non-fouling surfaces and tuning of cellular adhesion through choice of protein precursor.  
2.2.Results and Discussion 
We hypothesized that the combination of temperature and pressure provided using 
thermal NIL could be used to create stable protein films with minimal loss of protein 
structure, and without the use of additives.  This NIL-based strategy for generating 
protein films would allow us to greatly expand the range of protein building blocks from 
the subset of naturally self-assembling proteins to the full range of readily available 
proteins.  Importantly, retention of protein structure in the NIL process would provide 
effective translation of protein properties, such as surface charge, to the macroscopic 
properties of the films.  These hypotheses were tested using three readily available 
proteins that do not natively self-assemble: anionic bovine serum albumin (BSA, MW 
66.3 kDa, pI 4.8), neutral hemoglobin (Hemo, MW 64.5 kDa, pI 6.8), and cationic 
lysozyme (Lyso, MW 14.3 kDa, pI 11).        
Precursor protein films were generated by spin-casting 10 % w/w aqueous 
solutions of protein onto plasma cleaned substrates (Figure 2.1a).  The films were ~200 
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nm in thickness as determined by ellipsometry and atomic force microscopy (Figure 2.2).  
The spin-cast films were next imprinted/embossed by using a fluorosilane-functionalized 
mold.  The NIL conditions were parametrically varied to identify the factors that 
determine the aqueous stability of the imprinted protein films (Figure 2.1b); the results 
demonstrate that both pressure and heat are required for generating stable protein films, a 
synergistic behavior that had not been previously probed.  Stable films were generated 
from all three proteins at temperatures greater than 140 °C and pressures of 2.8 MPa, 
with variation observed in the pressure/temperature profile of the individual protein, a 
natural consequence of the dramatically differing structures of the precursor proteins. 
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Figure 2.1: Method and optimized conditions used for imprinted protein film fabrication. 
a) Proteins were spin-cast and then imprinted/embossed using temperature and pressure 
to generate stable planar and patterned surfaces.  These surfaces retain properties of the 
precursor proteins that can be employed for a range of applications. b) Plots showing the 
effect of pressure and temperature on film stability in water. Films were washed for 1 min 
with water and the thickness measured by ellipsometry after drying, with water stability 
observed only when heat and pressure are combined. 
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Figure 2.2: AFM images and cross-sections of scratched protein films. The protein films 
made by BSA, Hemo, and Lyso were scratched by blade and the film thicknesses were 
determined by measuring the height differences made by scratching. 
The secondary protein structure of the components within the films was 
characterized using circular dichroism (CD) spectroscopy.22 (Figure 2.3a-c)  The 
substantial retention of secondary structure indicates that a more subtle mechanism of 
film stabilization than complete denaturation is operative.  We hypothesize that the 
elevated temperature of the nanoimprinter causes flexibility of the random coil segments 
of the peptide backbone, while the pressure limits conformational reorganization of the 
protein structure.  The origin of the film stability was probed through use of traditional 
protein denaturants.  Treatment of the films with 2-mercaptoethanol did not disrupt the 
films, ruling out inter-protein disulfide bonds as the stabilizing factor.23  In contrast, 
treatment with a surfactant (sodium dodecyl sulfate, SDS) rapidly disrupted the films, 
indicating that inter-protein hydrophobic interactions imparts the observed stability of the 
film to aqueous media.24 (Figure 2.4)  
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Figure 2.3: Structural characterization of protein films a) CD spectra of BSA.  b) CD 
spectra of Hemo.  c) CD spectra of Lyso. The individual proteins in phosphate buffer are 
also shown for comparison.  d) Surface potential of individual protein films as 
determined by Kelvin probe force microscopy (KPFM).  e) Thickness change in protein 
films measured by ellipsometry after 48 hrs of incubation in 10 % serum solution.  f)  
Thickness change in protein films measured by ellipsometry after 24 hrs of incubation in 
0.01 % trypsin solution. 
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Figure 2.4: Thickness changes of protein films after incubating with 0.5 M 2-
mercaptoethanol (2-ME) and 10% sodium dodecyl sulfate (SDS) for 48 hours. The 
thickness was measured by ellipsometry and the percentage changes were calculated by 
comparing the thicknesses of protein films before and after treating with 2-ME or SDS. 
SDS was used for disrupting hydrophobic interaction and 2-ME was able to break 
disulfide bonds of protein films. The results indicated that the protein films were 
stabilized mainly by hydrophobic interactions.  
 
The retention of protein structure in the imprinted films implied that the choice of 
protein could be used to dictate the charge of the resulting macroscopic films, an 
important tool for numerous applications.  Kelvin probe force microscopy (KPFM) 25 was 
used to measure the local work function difference between the metallized probe (Pt) and 
the protein surfaces.26  Figure 2.3d (along with Figure 2.5) shows histograms of measured 
surface potential contrast (SPC) relative to the evaporated gold supporting substrate.  As 
expected based on precursor protein charge, the BSA surfaces present a negative surface 
 27 
 
potential, while the Lyso film possesses a positive surface potential. Hemo showed a near 
neutral potential, consistent with its near neutral pI.  The retention of charge was further 
probed through charge-selective adhesion of positively and negatively charged quantum 
dots (Figure 2.6), supporting that the surface charge differences established by KPFM 
translate into functional control of adhesion. 
 
Figure 2.5: Kelvin probe force microscopy analysis of the protein films.  a) Surface 
potential contrast measurement of gold substrate.  Below is the line section profile.  b) 
Surface potential contrast measurement bovine serum albumin.  Below is the line section 
profile.  c) Surface potential contrast measurement of hemoglobin.  Below is the line 
section profile.  d) Surface potential contrast measurement of lysozyme.  Below is the 
line section profile.   
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Figure 2.6: Adhesion of functionalized quantum dots (QDs) to protein films. a) The 
chemical structures of surface functionalities on QDs. The charged QDs were used as 
probes for the surface charges of protein films by interacting with protein films through 
electrostatic interaction. b,c) 10 µL 1 µM QD probes were dropped on the protein films 
and incubated for 15 mins in a humid chamber to avoid drying. After incubation, the 
protein films were washed by Milli-Q water 5 times. Then the surface charges of protein 
films were determined by the fluorescent responses under the irradiation of a UV lamp at 
365 nm.  For the BSA film, only the positively charged probe showed a strong 
interaction, indicating that BSA film is negatively charged. The Lyso film showed the 
opposite result due to its inherent positive charge.  
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We next focused on biomaterial applications for these NIL protein films.  The 
inherently zwitterionic surfaces of soluble proteins is essential in inhibiting their 
aggregation in solution.1  The retention of surface properties should therefore provide 
resistance to protein fouling, an important requirement for both implantable devices and 
for ex vivo applications.27,28  We evaluated resistance to protein deposition of our films by 
incubating films in 10 % serum solutions for 48 hrs and then measuring the film 
thicknesses by ellipsometry.  As shown in Figure 2.3e, there were no significant increases 
in film thicknesses, indicating that the films are resist non-specific protein adsorption.  
We further tested the response of the films to the intracellular protease trypsin, as 
controlled degradation of scaffolding plays an important role in interfacing materials with 
biological systems.12,14   After incubating in 0.01 % w/w trypsin solution for 24 hrs, BSA 
and Hemo films fabricated at 180 °C were resistant to trypsin hydrolysis.  All films 
imprinted at 150 °C, however, were degraded (Figure 2.3f), making these films 
promising candidates for controlled-release applications.29  
Previous studies have demonstrated that charged molecules on surfaces are 
important for directing cellular adhesion, with more efficient attachment observed with 
positively charged surfaces.30  Based on our ability to control the surface charge of the 
imprinted protein films, functional demonstration of the differences in film properties 
was obtained through cell adhesion studies.  NIH-3T3 fibroblast cells were seeded onto 
protein films for 48 hrs and stained with calcein-AM.  Fluorescence microscopy images 
show that films made from negatively charged BSA and neutral Hemo cells had limited 
adhesion on films fabricated at 150 °C (Figure 2.7a) while the films fabricated at 180 °C 
(Figure 2.7b) demonstrated no measurable adhesion.  In contrast, Lyso films provided 
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excellent adhesion at both processing temperatures, consistent with the expected higher 
cellular adhesion by the cationic surface.30    
 
Figure 2.7: Cellular adhesion to protein films.  Adhered cells on protein films generated 
at a) 150 °C and b) 180 °C were stained with calcein-AM after 48 hrs.  Scale bars 
represent 100 µm. 
 
The NIL process used in our method provides direct access to nanoscale 
patterning that can be used to dictate cellular alignment, a feature that subsequently can 
be translated into tissue formation.30  Based on the cellular adhesion studies, Lyso was 
chosen to investigate cell alignment based on nanopatterning. As shown in Figure 2.8a 
inset and Figure 2.9a, the Lyso film was texturally patterned using a fluorosilane-
functionalized master mold with a 300 nm grooved pattern.  Next, NIH-3T3 fibroblast 
cells were cultured onto the patterned film.  As shown in Figure 2.8b and Figure 2.9b, 
cells were fixed, stained with phalloidin to visualize actin filaments, and alignments were 
measured by optical microscopy. Figure 2.8a shows that a majority of the cells aligned 
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with the nanoscale pattern, demonstrating that the film properties and patterning provided 
by the NIL process can be used synergystically to direct cellular growth.  
 
Figure 2.8: Cellular adhesion and alignment with patterned surfaces. a) Percentage of 
cells aligned along the imprinted pattern.  Inset is a 3D atomic force microscopy image of 
the Lyso film generated with a patterned mold.  b) Fluorescence micrograph of fibroblast 
cells cultured on the patterned Lyso film.  Cell nuclei were stained with Hoechst 33342 
and actin filaments were stained with phalloidin.  
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Figure 2.9: Cell culture adhesion and cellular alignment with patterned surfaces.  a) 3D 
atomic force microscopy image of the lysozyme film generated with a patterned mold.  b) 
Fluorescence micrograph of fibroblast cells cultured on the patterned lysozyme film.  
Hoechst (left) was used to stain cell nuclei and phalloidin (right) to stain actin filaments.  
Scale bars are 50 µm. 
 
2.3. Conclusions 
In summary, we have demonstrated that the controlled heat and pressure provided 
by thermal NIL generates water-stable films from a range of precursor proteins.  These 
films are generated without additives and in an environmentally benign fashion.  The 
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proteins retain substantial native protein structure, which renders them biocompatible and 
resistant to protein fouling.  The films also integrate the intrinsic physical properties of 
the precursor proteins, allowing surface charge and stability to be tuned by choice of 
precursor protein and processing conditions.  This bottom-up method is generalizable, 
indicating it can use the enormous variety of naturally occurring and engineered proteins 
to generate films with a commensurate range of properties.  Furthermore, the readily 
scalable NIL based method is multimodal, as the process both influences the stability of 
the films and introduces nanoscale architectural features.  Taken together, the ability to 
generate stable protein films using NIL provides an enabling technology for a broad 
range of applications ranging from biomedicine to sustainable consumer materials.   
2.4. Experimental Methods 
2.4.1. Materials  
BSA, Hemo, and Lyso were purchased from Fisher Scientific and used without further 
purification. Silica wafers were purchased from WRS Materials. Quartz microscopy 
slides were purchased from Electron Microscopy Sciences. MilliQ water was purified by 
using a Millipore water purification system. 
2.4.2. Film Preparation  
10 % w/w solutions of protein in MilliQ water were filtered by using a 0.22 µm filter and 
spin-coated at 3000 rpm for 60 s onto an oxygen plasma cleaned silicon substrate, 
yielding a thin film of protein. 
2.4.3. Nanoimprint Lithography (NIL) 
Nanoimprinting of protein films was performed by using a Nanonex NX-2000 
nanoimprinter with silicon molds. Imprinting was performed at various temperatures and 
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pressures for 5 min. A silicon NIL mold (line width 303 nm, period 606 nm, and groove 
depth 190 nm) from Lightsmyth Technologies was used in the cell patterning. All molds 
were treated with heptadecafluoro-1,1,2,2-(tetrahydrodecyl)dimethyl- chlorosilane at 75 
°C for 2 days in a vacuum chamber. 
2.4.4. Kelvin Probe Force Microscopy (KPFM) 
10 % w/w solutions of protein in MilliQ water were filtered using a 0.22 µm filter and 
dropcast onto an oxygen plasma cleaned gold substrate, yielding a thin film of protein.  
Nanoimprinting of the protein films was performed by using a Nanonex NX-2000 
nanoimprinter with flat silicon molds at 180 °C and 2.8 MPa.  The KPFM was conducted 
with platinum coated tips (ANSCM-PA) purchased from AppNano on a Digital 
Instrument atomic force microscope under ambient temperature and atmospheric 
conditions.  
2.4.5. Cell Culture 
Mouse fibroblast cells 3T3 (ATCC CRL-1658) were cultured in Dulbecco's modified 
Eagle's medium (DMEM; ATCC 30-2002) supplemented with 10% bovine calf serum 
(ATCC 30-2030) and 1 % antibiotics in T75 flasks. Cells were maintained at 37 °C in a 
humidified atmosphere of 5 % CO2 and were sub-cultured once in 4 days. 
2.4.6. Cell Adhesion  
3T3 cells grown in T75 flasks were washed with phosphate buffered saline (PBS), 
trypsinized with 1X trypsin and collected in DMEM media. Cells were centrifuged and 
were re-suspended in fresh DMEM media and counted by using a hemocytometer. 
Protein film coated surfaces were placed in a six-well plate where 3T3 cells were added 
to each well (100000 cells/well) and incubated for 48 h at 37 °C in a humidified 
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atmosphere of 5 % CO2. Following incubation, cells were washed with phosphate-
buffered saline (PBS) three times and incubated with calcein AM (Biotium Inc, 80011-2) 
and propidium iodide (Invitrogen) in PBS (final concentration 3 μM each) for 30 min. 
Fluorescence microscopy images were taken by using an Olympus IX51 microscope to 
visualize the adhered live (Calcein AM stained, green) and dead cell (propidium iodide 
stained, red) population in each surface.  
2.4.7. Cell Alignment on Nano-patterned Surfaces 
The cell alignment on the patterned surfaces were performed according to previously 
published procedures.30 Briefly, 100000 cells were incubated with the nano-patterned 
surface for 48 h and washed twice with pre-warmed PBS and fixed with 3.7 % methanol-
free formaldehyde solution (Electron Microscopy Sciences 15714-S). Cells were then 
washed three times with PBS and extracted with 0.1 % Triton X-100 in PBS for 5 min. 
Surfaces were then washed with PBS and incubated with a solution of Oregon Green 488 
phalloidin (Invitrogen O7466) to stain actin filaments and Hoechst nuclear stain 
(Invitrogen H1399) at final concentrations of 200 nM and 1 μg/mL respectively in PBS. 
After 30 minutes, the cells were washed three times and the images were captured using a 
confocal microscope (Olympus). Cell alignment was measured by using ImageJ software 
by determining the angle of the long axis of the nucleus with respect to the parallel 
direction of the pattern. 45 random cells from each image were counted according to their 
angle of alignment from 0 ° to 90 ° in 10 ° increments and their percentage distribution 
was graphed. 
2.4.8. Characterization  
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Bright field images and fluorescence were detected by using an Olympus IX51 
microscope with excitation wavelengths of 470 nm and 535 nm. AFM imaging of the 
surfaces was done on a Dimensions 3000 (Veeco) in tapping mode using a RTESP7 tip 
(Veeco). Confocal images were obtained by using a Zeiss LSM 510 Meta microscope. 
The film thickness of the protein films was measured by a Rudolph Research Auto EL 
ellipsometer. Far-UV circular dichroism (CD) spectra were measured on a JASCO J-720 
spectropolarimeter with a quartz cuvette of 1 mm path length at 25 °C. The spectra were 
recorded from 200 to 260 nm as an average of three scans at a rate of 20 nm/min.  
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CHAPTER 3 
MIXED PROTEIN FILMS AS TUNABLE BIOMATERIAL PLATFORM 
3.1. Introduction 
Protein derived materials offer an inherently sustainable and structurally diverse 
platform for the fabrication of functional materials.1,2,3 Protein films provide particularly 
attractive scaffolds for biomaterials, combining biodegradability and biocompatibility in 
versatile materials comprised of natural precursors.4,5,6 Furthermore, the protein surface 
creates a molecular template for controlling interactions with biological systems.7,8,9  
These favorable attributes have made these protein-based materials highly amenable to 
interface with cells for tissue engineering10,11 and wound healing12,13 applications.   
Recently, we have developed an additive free, nanoimprint lithography (NIL) 
based method for the generation of water stable protein films.14  Based on previous 
studies of patterned and multicomponent thin films,15,16,17 we hypothesized that inkjet 
printing of proteins would provide a suitable method for the “direct-writing” of two-
dimensional biomolecular patterns to complement our NIL protein film fabrication 
strategy.  Herein, we describe a combined inkjet printing based deposition with 
nanoimprint lithography stabilization methodology generates materials surfaces with 
tunable biological interactions.  The utility of these films was demonstrated through the 
controlled adhesion and migration of mammalian fibroblasts as well as bacteria.  This 
versatile nanomanufacturing platform is a promising system for the rapid prototyping of 
new biomaterials with tunable surface properties.      
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3.2. Results and Discussion 
Inkjet printing provides a reproducible method for controlling the mixing and 
deposition of nanomaterials.18  Previous studies have demonstrated that proteins can 
readily be inkjet printed without vastly altering the intrinsic properties of the protein.19  
We hypothesized that the parametric control offered by inkjet printing would allow us to 
dial in the biological response to combinatorial protein films.  As shown in Figure 3.1, 
inkjet deposition of protein-based inks generates micron-patterns whose components can 
be modularly assembled.  Following this directed deposition, the proteins are stabilized 
into a functional film using an additive free, nanoimprint lithography based method that 
is stable to cell culture conditions as described in Chapter 2.  This NIL methodology is 
crucial for film stabilization as the process is not dependent on the protein precursor used 
and does not add biologically adverse substances to the film.      
 
Figure 3.1: Schematic of film processing strategy to generate protein films.  Inkjet 
directed deposition controls both the film composition and spatial presentation of the 
protein components. 
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We chose to probe cellular adhesion as a model biological response as the 
regulation of cellular adhesion/migration has been shown to be a critical factor in a 
variety of biological processes including cell differentiation.20 tissue development.21 and 
cancer progression.22  Bovine serum albumin (BSA, MW 66.3 kDa, pI 4.8) and lysozyme 
(Lyso, MW 14.3 kDa, pI 11) were selected as our model anionic and cationic protein 
inks, respectively.  Films were generated through the deposition of the protein inks in a 
parametric fashion.  Film composition was varied from 100 % BSA to 100 % Lyso in 20 
% increments.  Each ratio displayed a similar roughness and thickness indicating that the 
surface interactions of the film with its environment should be entirely electrostatic in 
nature. (Table 3.1)   
Table 3.1: Thickness and roughness of protein films with different ratio of BSA 
and Lyso. The thickness was measured using ellipsometry (n=5) and the roughness was 
obtained by AFM.  
 
Composition Thickness (nm) Roughness (nm) 
100 % BSA 134.9 ± 0.3 0.55 
20 % Lyso 134.2 ± 0.1 1.039 
40 % Lyso 136.3 ± 2.6 1.095 
60 % Lyso 136.8 ± 3.3 3.144 
80 % Lyso 133.6 ± 0.4 4.829 
100 % Lyso 134.8 ±1.1 0.72 
 
The deposition of functionalized nanoparticles was quantified using laser ablation 
inductively coupled plasma mass spectrometric imaging (LA-ICP-MSI) to probe the 
successful incorporation of protein charge into the properties of the film.23,24  Surface 
functionalized gold nanoparticles (AuNPs) are an ideal probe for understanding 
supramolecular interactions at a biologically relevant scale.25  We incubated the films 
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generated from varying ratios of proteins with AuNPs possessing either cationic or 
anionic headgroups.  Using LA-ICP-MSI, we characterized the adhesion of the AuNPs 
with respect to their complementary interactions with each film constituent.  As shown in 
Figure 3.2a, b, the cationic AuNPs selectively adhere to BSA containing films whereas 
the anionic AuNPs were adsorbed to the Lyso films.  These results indicated that the 
intrinsic protein charges were successfully incorporated into the film and the overall 
property of protein film was tunable with respect to complementary electrostatic 
interactions. 
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Figure 3.2: Adhesion of a) cationic and b) anionic AuNPs as determined by LA-ICP-
MSI.  Protein films were generated by varying the BSA:Lyso ratio of the film in 20 % 
increments.  Scale bars are 500 µm. 
Next, we determined whether this physiochemical response to nanomaterial 
interfaces was translatable to biological systems.  We quantified the adhesion of 
mammalian fibroblast cells using films generated from increasing ratios of BSA:Lyso.  
As shown in Figure 3.3, cells adhere to films generated with greater percentages of Lyso 
with a drastic increase observed with films comprised of 80 % or more of Lyso.  Films 
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fabricated with higher BSA amounts demonstrated minimal adhesion confirming the 
incorporation of protein charge into the overall materials properties of the film.  
 
Figure 3.3: Adhesion of mammalian fibroblasts on films with varying ratios of protein 
components.  a) Cells were stained with Hoescht 33342 and Calcein AM to label the cell 
nuclei and cytosol, respectively.  Scale bars are 200 µm. b) Average number of cells per 
mm2 as determined using image analysis. (see Figure 3.12)  
 
We generated a gradient where the BSA:Lyso ratio was varied to further probe 
the adhesion based on the composition of mixed protein component.  As shown in Figure 
3.4a, c, the cells preferentially adhere to the Lyso containing portion of the film.  
Notably, the films ratiometric and gradient patterns demonstrate highly correlative results 
underpinning the robustness with which biomaterial properties can be dialled in through 
modular assembly.   
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Figure 3.4: Adhesion of mammalian fibroblasts on micropatterned films. a)  Cell 
adhesion to protein film generated with a gradient pattern.  Cells were stained with 
Hoescht 33342 and Calcein AM to label the cell nuclei and cytosol, respectively.  b) Cell 
adhesion to patterned film with discrete Lyso and BSA domains.  The solid line (Lyso) 
and dotted line (BSA) were drawn to aid the eye.  c)  Number of cells with respect to 
position along gradient as determined using image analysis. (see Figure 3.13)  d)  
Fluorescence micrograph of cells adhered to Lyso pattern surrounded by BSA.  Scale 
bars are 100 µm for a), 200 µm for d), and 1 mm for b). 
 
Inkjet printing advantageously affords spatial control over the deposition of film 
components.  We deposited a rectangle of Lyso surrounded by a circle of BSA to probe 
the dependence of cellular adhesion as a function of geometric deposition.  As shown in 
Figure 3.4b, d, the cells preferentially adhere to the Lyso pattern and can be easily 
washed away from the BSA coated surface.  This dynamic process of cellular attachment 
was also observed at the boundary of BSA and Lyso patterns as shown in Video 3.1. 
We next tested the generality of the observed selective adhesion using a model 
bacteria strain, Escherichia coli DH5α (E. coli).  The bacteria strain was induced to 
express the red fluorescent protein td-Tomato in order to readily image the adhered 
bacteria.  As shown in Figure 3.5, the bacteria preferentially adhered to the lysozyme rich 
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films.  This observation is in agreement with previous studies that demonstrate the 
negatively charged bacterial cell walls adhere to anionic surfaces.26   
 
Figure 3.5: Fluorescence micrographs showing the adhesion of E. coli DH5α expressing 
red fluorescent protein after 1 day of incubation.  Scale bars are 50 µm.  
 
3.3. Conclusions 
In conclusion, we have developed a highly modular method to generate stable 
protein films in a rapid fashion with diverse components.  The environmentally friendly 
processing taken with the parametric control over the surface chemistry provides a 
multidimensional platform for understanding and controlling biological interactions with 
protein coated surfaces.  Due to the minimal waste inherent to inkjet deposition 
incorporating engineered proteins into robust, bioactive films.  Additionally, this strategy 
is readily translatable into a roll-2-roll methodology to generate biomaterials in a high-
throughput fashion for potential wound healing and tissue engineering applications.   
3.4. Experimental Methods 
3.4.1. Materials 
Bovine serum albumin (BSA) and lysozyme (Lyso) were purchased from Fisher 
Scientific and used without further purification. Silica wafers were purchased from WRS 
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Materials.  Glass microscopy slides were purchased from Fisher Scientific.  MilliQ water 
was purified by using a Millipore water purification system.   
3.4.2. Synthesis of TTMA and Carboxylate AuNPs  
Gold nanoparticles were synthesized according to previously reported methods.27,28  
Briefly, the Brust-Schiffrin two-phase synthesis method was used to synthesize 
pentanethiol-coated AuNPs with core diameter ca. 2 nm.29,30 Murray place-exchange 
method31 was followed to obtain the ligand-protected AuNPs.  Pentanethiol-conjugated 
AuNPs (20 mg) and thiol ligand (60 mg) were dissolved in a mixture of dry DCM (6 ml) 
and methanol (2 ml) and stirred under N2 atmosphere for 3 days at room temperature.  
The solvents were removed under reduced pressure and the resulting precipitate was 
washed with hexane (20 ml) three times and DCM:hexane mixture (1:1 v/v, 20 ml) four 
times.  Then the precipitate was dissolved in distilled water (~ 8 ml) and dialyzed for 
three days (membrane molecular weight cut-off =10,000, volume of the dialysis bucket is 
5 L) to remove excess ligands, pentanethiol, acetic acid, and other salts present in the 
nanoparticle solution.  After dialysis, the particle was lyophilized to yield a solid 
brownish product.  The particles were then re-dispersed in deionized water.  
3.4.3. Mass Spectrometric Characterization of Ligand Composition 
Matrix assisted laser desorption/ionization mass spectroscopy (MALDI-MS) has been 
performed to characterize the surface ligand on the AuNPs (Figure 3.6 and 3.7).32 A 
saturated α-Cyano-4-hydroxycinnamic acid (α-CHCA) stock solution was prepared in 
70% acetonitrile, 30% H2O, and 0.1% trifluoroacetic acid. An equal volume of 2 μM NP 
solution was added to the matrix stock solution. 2.5 μL of this mixture was applied to the 
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sample carrier, and then the MALDI-MS analysis was performed on a Bruker Autoflex 
III mass spectrometer.  
 
Figure 3.6: Matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS) 
spectrum of TTMA NPs. [MH]+ = 422.33. 
 
 
 
Figure 3.7: Matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS) 
spectrum of carboxylate NPs. [MH+2Na-H-H2S]
+ = 449.25. 
 
3.4.4. Dynamic Light Scattering (DLS) 
DLS experiments and zeta potential measurements were performed using a Malvern 
Zetasizer Nano ZS.  Samples were sonicated prior to measurements. 
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Figure 3.8: DLS measurements of TTMA NPs was obtained in 5 mM phosphate buffer at 
pH 7.4. The average size was 10.3  2.42 nm.  
 
 
 
Figure 3.9: Zeta potential of TTMA NP was measured by DLS in 5 mM phosphate buffer 
at pH 7.4. The overall charge of this cationic TTMA NPs is measured as 21.1 ± 5.93 mV. 
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Figure 3.10: DLS measurements of COOH NPs was obtained in 5 mM phosphate buffer 
at pH 7.4. The average size was 10.2  2.06 nm. 
 
 
Figure 3.11: Zeta potential of COOH NP was measured by DLS in 5 mM phosphate 
buffer at pH 7.4. The overall charge of this anionic AuNPs is measured as -43.1   4.71 
mV. 
 
3.4.5. Inkjet Deposition of Protein Inks  
The inkjet printing was done using an Epson Artisan 50 inkjet printer.  The BSA and 
Lyso were diluted to a concentration of 5 wt% with 80:20 volume ratio of water/ethanol 
solution, filtered through a 0.2 µm polypropylene membrane (Puradisc 25AS, Whatman), 
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and syringed into a virgin aftermarket Epson inkjet cartridge for printing (MIS 
Associates, Auburn Hills, MI USA). For this work, the BSA solution was loaded in 
magenta channel and the lysozyme solution was loaded in cyan channel.  Printing was 
done using an Epson Artisan 50 inkjet printer (Long Beach, CA USA) which was used as 
packaged.  The glass substrate was loaded into the printer by taping the bottom of the 
substrate to the included CD tray.  Patterning was done by using the Print CD software 
provided with the Epson printer. In order to print only the channel of interest, the color of 
the pattern has to match the channel printed.  To print only the magenta channel, the RGB 
value must be set to (255,0,255); the cyan channel, (0,255,255).  The ICM color 
management also must be turned off in the Advanced tab of the printer properties to 
ensure no mixing of the channels occurs.  To print BSA/Lyso mixed patterns, the ratio of 
magenta/cyan were converted into corresponding RGB value on the website: 
http://web.forret.com/tools/color.asp.  The gradient pattern from 100% BSA to 100% 
Lyso was made by color gradient tool in the Print CD software.  Before printing, the 
printheads were cleaned two times using the “Head Cleaning” function in the 
Maintenance tab of the printer properties to ensure that the channels were filled. 
3.4.6. Nanoimprint Lithography 
Nanoimprinting of protein films was performed by using a Nanonex NX-2000 
nanoimprinter with flat silicon molds.  Imprinting was performed at 180 °C and 2.8 MPa 
for 5 min.  All molds were treated with heptadecafluoro-1,1,2,2-
(tetrahydrodecyl)dimethyl-chlorosilane at 75 °C for 2 days in a vacuum chamber prior to 
use. 
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3.4.7. Cell Culture  
NIH 3T3 cells were cultured in a humidified atmosphere (5 % CO2) at 37 °C, and grown  
in Dulbecco’s modified Eagle’s medium (DMEM, low glucose) supplemented with  10 %  
fetal  bovine  serum  (FBS) and 1 % antibiotics (100 U/mL penicillin and 100 μg/mL 
streptomycin).   
Cell adhesion experiments were performed by incubating 150,000 NIH 3T3 cells with 
protein coated silica wafers placed in a 12-well plate for 1 h.  The surfaces were then 
washed by cold phosphate buffer saline (PBS) 3 times to remove floating cells, followed 
by incubation with 1 mL of fresh media for 23 h.  Cells were then stained with Calcein 
AM and Hoescht 33342 to label cytosol and nucleus, respectively, for fluorescent 
microscopic imaging according to the protocol from Life Technology using an Olympus 
IX51 microscope with excitation wavelengths of 470 nm and 535 nm. 
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Figure 3.12: Cell counting data on mixed protein films of varying protein ratios were 
obtained using ImageJ software.  Box dimensions are 250 µm x 250 µm. 
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Figure 3.13: Cell counting data on gradients were obtained using ImageJ software.  Box 
dimensions are 1000 µm x 200 µm. 
 
Live cell video imaging was performed by incubating 300,000 NIH 3T3 cells with 
protein patterned glass slides in a 35 mm petri dish for 1 h.  Slides were then washed with 
PBS 3 times to remove floating cells, the petri dish was filled with 4 mL of fresh media 
and placed into a CO2 chamber with temperature control on the microscope. Optical 
images of cells were then continuously recorded using an Olympus IX51 microscope 
every 15 min for 8 h. 
3.4.8. Bacteria Adhesion Studies 
Bacteria were inoculated in 3 mL LB broth and grown to stationary phase at 37 °C. The 
cultures were then diluted in M9 broth supplemented with 1 mM IPTG (isopropyl β-D-1-
thiogalactopyranoside). 2 mL of the dilution was transferred into the wells of a 24 well 
plate containing Silicon coated surfaces (22 × 22 mm). The 24 well plate was kept at 25 
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°C and the biofilms were allowed to grow for 24 hours. In general, the surfaces with 
biofilms were rinsed in deionized water for three times before imaging. 
3.4.9. Inductively Coupled Plasma Mass Spectrometry Imaging  
For the characterization of the nanoimprinted protein samples, we used laser ablation-
inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging.  Imaging was 
done using a CETAC LSX-213 G2 laser ablation system (Photon Machines, Omaha, NE, 
USA) attached via a 2 m length of tubing to a Perkin Elmer NEXION 300X ICP mass 
spectrometer.  Prior to analysis of the samples, we dropped a 1 µL of TTMA and COOH 
functionalized AuNPs separately.  Then, using imaging, we generated Au map 
distribution of these AuNPs on the nanoimprinted surfaces.  The parameters used for the 
imaging experiment can be found on Table 3.2. 
Table 3.2: Experimental conditions used for LA-ICP-MS analysis. 
 
Laser ablation parameters ICP-MS parameters 
Spot size 50 µm Rf power 1.6 kW 
Scan rate 10 µm/s Nebulizer flow rate 0.7 L/min 
Laser energy 3.34 J Plasma flow rate 16.5 L/min 
Frequency 10 hz Auxiliary flow rate 1.4 L/min 
Carrier gas flow 
rate (Helium) 
0.6 L/min Pulse and Analog 
stage voltages 
950 V(Pulse), 
-1600 V(Analog) 
 Deflector voltage -12 V 
Dwell time 50 ms 
 
Using the parameters show on the Table 3.2, imaging experiments were performed to 
obtain Au maps of the samples.  The results obtained from ICP-MS analysis were further 
processed using Excel and then images of the samples were generated using ImageJ 
software.  To obtain quantitative images of the samples, chicken breast tissues were 
purchased from a local market and they were homogenized using PowerGen 125 
homogenizer.  Homogenized tissues were centrifuged at 12000 rpm for 5 minutes and the 
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powders precipitated were collected.  5 aliquots of 50 mg of homogenate were weight 
and placed into 0.5 mL tubes.  Different concentration of AuNPs (0, 0.125, 0.25, 0.5 and 
1µM) were injected into these 50 mg aliquots and frozen to be sliced.  The frozen block 
of sample then sliced to 12 µm thickness using a LEICA CM1850 cryostat.  The sliced 
tissues were imaged under the same conditions following the analysis of the 
nanoimprinted samples.   
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CHAPTER 4 
NANOZYME-BASED OLFACTORY SYSTEM ENHANCER (NOSE)  
4.1. Introduction 
Odorous compounds function as potent sensory agents eliciting almost 
immediate and primal human responses.  The human olfactory system has 
evolved to be capable of detecting extremely low concentrations of volatile 
organic compounds present in complex environments.1  Furthermore, humans can 
discriminate more than 1 trillion olfactory stimuli, several orders of magnitude 
greater than their capability of visual discrimination.2  For example, the aromatic 
compounds generated during the Maillard reaction offer rare insights into the 
countless chemical transformations that occur during this redolent process.3,4  
However, a variety of biological and non-volatile chemical interactions are 
transient and remain undetectable to humans without these small molecule 
products.5      Consequently, translating reversible molecular events into a signal 
that is interpretable by the human olfactory system continues to be an elusive 
goal.   
Nanotechnology provides a unique avenue to redefine the bounds of 
human perception.6  In particular, engineering the surface of nanomaterials is a 
powerful strategy to direct interactions at the molecular level. 7  Previously, 
surface functionalized gold nanoparticles have been used to generate array-based 
sensors,8 regulate enzymatic activity, 9 and influence cellular growth on 
surfaces.10  The proximate response to the nanomaterials has been shown to be 
controlled in a surface moiety dependent fashion.11  Engineered nanomaterials 
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have also been shown to influence the behavior of fragrance molecules.12  In a 
recent study, Weder et al. demonstrated cellulose nanocrystals functionalized with 
pro-fragrance molecules could be used to control the production of volatile 
compounds.13  These covalently bound complexes remain odorless until certain 
functional groups are cleaved in response to specific external stimuli to generate 
the pungent aroma molecules.14  Taken together, we hypothesized that pro-
fragrances in combination with surface engineered nanomaterials could behave as 
reactive constructs to translate molecular interactions into scent.     
Herein, we describe a supramolecular-based approach to augment human 
olfactory perception.  The Nanozyme-based Olfactory System Enhancer (NOSE) 
readily complements the high sensitivity innate with the human olfactory system.  
The system is comprised of 3 tunable components: 1) pro-fragrance molecules, 2) 
surface functionalized nanoparticles, and 3) enzymes to cleave the pro-fragrances.  
The surface moieties of the nanoparticles behave as both selective recognition 
elements for analytes present in solution and to reversibly inhibit the complexed 
enzymes.  This recognition tactic shifts the primary detection onus from the 
olfactory bulb to the binding equilibrium established by the nanoparticle with the 
protein which has been shown to be highly dependent tunable based the surface 
functionality of the nanoparticle.15  We assessed the feasibility of our approach to 
expand human sensory capabilities by developing an olfactory-based bacteria 
sensor as a model supramolecular interaction.  The NOSE allowed human 
subjects to detect bacteria in solution at levels as low as 102 cfu/mL indicating the 
system could effectively enrich human olfactory faculties. 
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4.2. Results and Discussion 
We first sought to prototype our approach by creating a bacterial biosensor as 
bacteria-related illnesses from inadequate drinking water sources and improper sanitation 
practices contribute to over 1.5 million deaths worldwide a year.16,17  Our sensor design is 
based on the selective activation of an inhibited enzyme in the presence of bacteria 
(Figure 4.1).  Specifically, the sensor components are a cationic surface functionalized 
gold nanoparticle (AuNP), anionic Candida Rugosa lipase, and a pro-fragrance molecule, 
succinic acid monophenylethyl ester (SAME).  We chose AuNPs possessing ligands with 
terminal benzyl headgroups as these nanoparticles have been shown to both interact with 
the anionic cell surface of bacteria as well as inhibit enzymatic activity.18,19  We used 
Candida Rugosa lipase as a model, industrially relevant enzyme due to its robust 
characteristics and its ability to cleave ester bonds in a variety of conditions.20  Pro-
fragrances are volatile molecules that have been covalently modified to create a product 
that will generate the precursor fragrance upon cleavage of the covalent bond.21  The 
succinic acid ester of phenylethyl alcohol was chosen as our representative pro-fragrance 
as it produces a pleasant rose scent upon cleavage and phenylethyl alcohol has a low odor 
threshold.22  Figure 4.2 shows the NMR spectra of the synthesized pro-fragrance. 
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Figure 4.1: Schematic representation of sensor elements used in this study.  Cationic 
AuNPs bind with the anionic enzyme inhibiting the catalysis of the pro-fragrance into 
scent.  Bacteria present in solution compete for the AuNP surface and displace the 
enzyme inducing the production of the rose fragrance. 
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Figure 4.2: 400 MHz 1H NMR spectrum of the pro-fragrance, succinic acid 
monophenylethyl ester in chloroform-D (D-99.8 %).  Spectrum was obtained on a Bruker 
Avance 400 MHz, 16 scans. 
 
We initially performed a colorimetric assay to optimize the lipase to AuNP ratio 
needed for inhibition.  These studies were performed using a 0.15 nM lipase 
concentration in sodium phosphate buffer solution (5 mM, pH 7.4) incubated with 
various concentrations of benzyl AuNP for 30 minutes to generate the sensor complexes.  
10 µL of the colorimetric substrate p-nitrophenylbutyrate (pNPB, [0.6 mM], λmax = 405 
nm) was added to the sensor complexes.  As shown in Figure 4.3, a 3:1 AuNP to lipase 
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ratio completely inhibited the lipase.  This AuNP:lipase ratio was used to generate the 
nanozyme complex for all further studies.  
 
Figure 4.3: Lipase inhibition assay in the presence of benzyl AuNP. The same amount of 
lipase (15 nM) was incubated with a series of benzyl AuNP (from top to bottom: 0, 20, 
40, 60, 80, 100, 125, 150 nM) before adding the colorimetric substrate p-NPB (0.6 mM). 
After the substrate was added, the activity of lipase was monitored up to 2400 seconds 
(40 minutes). A control of p-NPB without the enzyme did not produce a signal.     
 
We used Escherichia coli XL1 (E. coli) as a model bacteria strain for our sensing 
studies with human participants.  Ten volunteers were asked to smell four different glass 
vials at two time points (1 minute and 15 minutes to ensure olfactory clearance23) that 
contain four conditions: buffer, sensor only (AuNP and lipase), NOSE in a solution of E. 
coli at 102 cfu/mL and sensor in a solution of E. coli at 104 cfu/mL.  Solutions of the 
sensor elements were incubated for 30 minutes prior to the addition of the pro-fragrance 
and bacteria.  Samples were then incubated for 15 minutes in 20 mL glass vials.  Each set 
of samples (four glass vials) was prepared individually for each participant.  Volunteers 
then used rank ordering to indicate the intensity of rose scent within the samples.  They 
ranked the samples in order from lightest smell to strongest smell with a scale from 1 to 
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5.  As shown in Figure 4.4, participants were successfully able to detect the rose scent in 
the presence of uninhibited lipase.  Notably, volunteers were able to detect E. coli 
concentrations at both 102 and 104 cfu/mL. 
  
Figure 4.4: Olfactory detection study in human. a) Lipase activity test in the presence of 
SAME was carried out with six participants. SAME only and 5 mM sodium phosphate 
buffer were used as the negative control. The hydrolyzed form of SAME was used as the 
positive control (strong standard). b) With ten participants, olfactory detection of E. coli 
at 102 and 104 cfu/mL were compared to the controls of just buffer and NOSE only. The 
olfactory signals from the vials which contained 102 and 104 cfu/mL of E. coli are 
significantly different from the signal from the NOSE-only vial.  Error bars represent the 
standard error of means for the measurements.  *= p< 0.05, ***=p<0.001. 
 66 
 
We next used headspace gas chromatography to quantify the production of 
scent by our bacterial sensor.  The concentration of the volatile product present in 
the headspace of the sample vial was quantified according to an external 
calibration curve (see Supporting Information).  As shown in Figure 4, the 
uninhibited lipase cleaves significantly more pro-fragrance than the NOSE and 
controls.  The control samples of the highest bacteria concentration tested with the 
pro-fragrance molecule and the sensor without bacteria did not produce a signal.  
The NOSE in the presence of 104 and 106 cfu/mL of E. coli showed a measureable 
signal that was significantly different.  However, 102 cfu/mL of E. coli did not 
produce a detectable signal under the conditions tested.  We hypothesize this 
discrepancy with the human studies to be a result of the complexities of human 
olfactory system. 
 
Figure 4.5: Calibration curve used to determine concentration of phenylethyl alcohol 
present in headspace of vials.  Samples were prepared by diluting phenylethyl alcohol 
into 5 mM sodium phosphate buffer.  Peak areas were determined using Origin 9.1 
software. 
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Figure 4.6: Headspace gas chromatography analysis of sensor response to increasing 
concentrations of bacteria.  Samples were prepared in triplicate.  Error bars represent 
standard deviations of the measurements.  *= p< 0.05, ***=p<0.001. 
 
4.3. Conclusions 
In summary, we report the development a supramolecular-based strategy to 
perceive molecular interactions with the human olfactory system.  As a proof of 
concept, our NOSE was shown to be an effective bacterial sensor based on the 
selective production of olfactory detectable compounds.  These studies 
demonstrated that by controlling the behavior at the molecular level of responsive 
nanomaterials we can alter how human beings observe their surroundings in a 
manner that is otherwise impossible.  We believe this responsive strategy can be 
broadly applied to other surface functionalized nanoparticles and enzymes to 
generate arrays of reversibly bound enzyme-nanoparticle complexes.  Further 
expanding this methodology allows the crafting of an almost limitless number of 
aroma profiles by using the readily available multitude of fragrance and enzyme 
combinations.  
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4.4. Experimental Methods 
4.4.1. Materials 
All reagents/materials were purchased from Fisher Scientific and used as received.  
Benzyl functionalized AuNPs were synthesized according to previous reports.24   
4.4.2. Synthesis of Pro-fragrance 
0.05 g of 4-dimethylaminopyridine and 0.983 g of succinic anhydride were dissolved in 
dry dichloromethane.   1 gram of phenylethyl alcohol was added to the reaction.  The 
reaction was heated and refluxed overnight.  Solvent was then removed and the product 
was dissolved in a saturated sodium bicarbonate solution.  Aqueous layer was extracted 
with ethyl acetate. (2x) Aqueous layer was then acidified and extracted with 
dichloromethane. (3x)  Dichloromethane layers were combined and dried over sodium 
sulfate.  Solvent was removed and the obtained product was a white crystalline solid.  
Yield = 1.655 grams, 91%,  m.p. = 68-70 ºC. 
4.4.3. Bacteria Growth Conditions  
Bacteria were cultured in LB medium at 37 °C and 275 rpm until stationary phase.  The 
cultures were then harvested by centrifugation and washed with 0.85 % sodium chloride 
solution for three times. Concentrations of resuspended bacterial solution were 
determined by optical density measured at 600 nm. 5 mM sodium phosphate buffer was 
used to make dilutions of bacterial solutions of 108,106, and 104 cfu/mL.  
4.4.4. Plate Reader Assay Conditions 
Lipase inhibition assay was done at 25 °C with the final concentrations in Costar clear 96 
well plate of 15 nM Lipase, 0.6 mM pNPB, and 20, 40, 60, 80, 100, 125, 150 nM benzyl 
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AuNP. Lipase and benzyl AuNP were first incubated for 30 minutes in 96 well plate to 
insure their interaction reaches equilibrium, then 10 µL of substrate p-NPB was added 
into the well. The activity of lipase was monitored every 30 seconds for a total of 40 
minutes time frame at the absorbance of 405 nm.   
4.4.5. Human Trial Assays 
4.4.5.1. Olfactory Detection of Lipase Activity  
Four different solutions were made in 20 mL glass vials with a final volume of 1 mL 
each.  5 mM sodium phosphate buffer and 4 mM SAME were used as the negative 
controls and the rose scent (2-Phenylethyl ethanol) was used as the positive control, a 
strong standard. The activity of lipase was assessed by incubating 100 nM of lipase with 
4 mM of SAME for 20 minutes. The participants were asked to smell these samples and 
rank them in the order from 1 to 5 with 1 has the lightest smell and 5 has the strongest 
smell.  
4.4.5.2. Olfactory Detection of E. Coli  
The same procedure was followed as above for buffer and sensor samples. For the E. 
Coli-containing vials, 100 nM Lipase was incubated with 300 nM Benzyl AuNP for 30 
minutes, and then 10 µL of E. Coli was added into each vial so that the final 
concentrations of E. Coli in each vial are 102 and 104 cfu/mL.  
4.4.6. Gas Chromatography Head-Space Analysis 
Headspace phenylethyl alcohol was measured using a gas chromatograph (model GC-
17A, Shimadzu Co., Tokyo, Japan) equipped with a solid-phase microextraction (SPME) 
auto injector (model AOC-5000, Shimadzu Co., Tokyo, Japan).  Samples (1 mL) in 20 
 70 
 
mL glass vials capped with aluminum caps with polytetrafluoroethylene (PTFE)/silicone 
septa.  Samples were prepared using 500 nM lipase, 1.5 µM benzyl AuNP, and 4 mM of 
SAME.  A 50/3 μm divinylbenzene (DVB)/carboxen/polydimethylsiloxane (PDMS) 
stable flex (SPME) fiber (Supelco Co., Bellefonte, PA) was then inserted into the vial 
headspace for 2 min to absorb volatiles.  The fiber was transferred to the GC injector port 
(250 °C) for 3 min.  The injection port was operated in split mode, and the split ratio was 
set at 20:1.  Volatiles were separated on a fused-silica capillary Equity-1 Supelco column 
(30 × 0.25 mm inner diameter × 25 μm) coated with 100% PDMS at an initial oven 
temperature of 70 °C to final temperature of 220 °C over 10 min (step rate 15 °C/min).  A 
flame ionization detector was used at a temperature of 250 °C.  Phenylethyl alcohol 
concentrations were determined from peak areas using a standard curve made from 
dilutions of phenylethyl alcohol in 5 mM sodium phosphate buffer.  Each measurement 
was performed in triplicate and results were expressed as mean values ± standard 
deviation. 
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CHAPTER 5  
HYBRID ORGANIC-INORGANIC COLLOIDAL COMPOSITE ‘SPONGES’ VIA 
INTERNAL CROSSLINKING 
5.1. Introduction 
Hybrid organic-inorganic nanocomposites have emerged as promising materials 
for a variety of applications such as photonic devices,1 proton exchange membranes,2 
emulsifiers,3 and encapsulation vehicles.4  The intimate interactions between the organic 
and inorganic components on the nanometer scale produce structures that display 
improved stability and generate materials with properties not achievable using the 
individual components alone.5,6 Modulation of the individual component compositions 
prior to composite formation provides further structural versatility arising from the 
'bottom-up' assembly process.7,8  Additionally, nanocomposites are readily amenable to 
post-functionalization, providing access to highly diverse functional structures on the 
nano and micro scales.9,10, 11,12,13    
The in situ generation of porous nanocomposites of controlled sizes with 
functional payloads, however, remains a challenge.14  Three widely used strategies for the 
creation of colloidal nanocomposites are in situ polymerization,15 sol-gel based 
approaches,16 and self-assembly.17  Previously, Armes et al. have created interfacially 
active nanocomposites through the polymerization of monomer emulsions stabilized with 
silica sols.18  van Blaaderen and coworkers developed a generalized method to produce 
hybrid colloids through the sol-gel deposition of inorganic precursors onto nanoparticles 
with adsorbed poly(vinylpyrrolidone).19  The work of Möhwald and Caruso harnessed the 
self-assembly of polystyrene beads with silica nanoparticles to form composite 
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structures.20  Pickering emulsions can also be used as self-assembled templates to 
generate complex functional materials.21,22,23  These hybrid systems, however, are 
generally used to form core/shell structures as opposed to solid nanocomposite structures.   
Herein, we describe a supramolecular/covalent strategy for the generation of 
hybrid organic-inorganic composites (Figure 5.1).  In this process, hydrophilic amine-
functionalized silica nanoparticles are assembled at the oil/water interface.  Reaction of 
the particles with a hydrophobic copolymer increases the hydrophobicity of the particles, 
resulting in particle migration into the oil phase and confining the covalent bond 
formation to the interior of the emulsions. These covalent linkages between nanoparticles 
and polymers induces a change in configuration from a reservoir system to a network 
composite while preserving the discrete microparticle morphology generated by the 
emulsion process.  These organic/inorganic hybrid systems are very robust, and show 
substantial retention of encapsulated hydrophobic payloads in the presence of ethanol 
without the need for post-functionalization or annealing after assembly. Furthermore, the 
use of non-toxic maleic anhydride-based polymers24 facilitates the potential use of these 
robust systems for a variety of medical and personal care applications.  
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Figure 5.1:  Schematic depiction of the method used to generate the crosslinked 
composites.  Water-soluble silica nanoparticles go to the oil/water interface to generate 
particle-stabilized Pickering emulsions.  The dissolved polymer in the oil phase reacts 
with the nanoparticles from the inside of the emulsion via a ring-opening reaction.  The 
crosslinking reaction simultaneously pulls the nanoparticles into the oil phase as the 
nanoparticle surface becomes more hydrophobic, generating an oil-containing composite 
structure. 
 
5.2. Results and Discussion 
5.2.1. Formulation of hybrid inorganic-organic nanocomposites 
Emulsions were generated according to the route depicted in Figure 5.1.  Briefly, 
the hydrophobic polymer was dissolved in the oil prior to emulsification, with limonene 
used as a model hydrophobic oil.  Concurrently, silica nanoparticles were suspended in 
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Milli-Q water and the solution was adjusted to a pH of 10 with sodium hydroxide to 
deprotonate the surface amines and promote covalent attachment to the polymer.25  The 
oil phase was added to the aqueous phase and homogenized at 24,000 rpm for two 
minutes.  Homogenization speeds lower than 24,000 rpm produced larger emulsions with 
higher degrees of polydispersity (Figure 5.2).  Stable emulsions could be formed at silica 
loadings ranging from 0.6 to 2.0 wt % (Figure 5.3, 5.4, 5.5).  Polymer loading into the oil 
phase did not appear to alter the emulsion morphology or size (Figure 5.6).  Emulsions 
were then allowed to crosslink overnight at room temperature. 
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Figure 5.2:  Photograph and bright field microscopy images of composites generated 
using different homogenization speeds.  Composites were generated by emulsifying 2 mL 
of 5 wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in 
Milli-Q adjusted to pH 10 for 2 minutes.  Homogenization speeds lower than 24,000 rpm 
resulted in larger emulsions with more polydispersity. 
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Figure 5.3: Image of composites after one week of storage.  Composites were generated 
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 0.6 wt % 
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.   
 
 
Figure 5.4: Image of composites after one week of storage.  Composites were generated 
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.2 wt % 
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.   
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Figure 5.5: Image of composites after one week of storage.  Composites were generated 
by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 2.0 wt % 
silica nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.   
 
Figure 5.6: Bright field microscopy images of composites generated with increasing 
polymer loadings in the oil phase.  Composites were generated by emulsifying 2 mL of 
varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in 
Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.   
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5.2.2. Composite characterization  
Confocal microscopy was used to probe the structure of the particle-stabilized 
emulsion droplets and visualize the assembly of nanoparticles at the oil/water interface.  
Amine-functionalized silica nanoparticles with cores containing fluorescein 
isothiocyanate (FITC) were used to track the location of the silica nanoparticles.  An 
aqueous dispersion of these nanoparticles was emulsified with the organic phase 
comprising limonene,  hydrophobic Nile Red dye and p-MA-alt-1-OD crosslinking 
polymer.  Figure 5.7a-d shows the co-distribution of the nanoparticles and the Nile Red 
containing oil phase, suggesting this system does not have the typical core shell structure 
of a Pickering emulsion.  The average size of the generated composites (2 mL of 5 wt % 
p-MA-alt-1-OD in Nile Red loaded limonene: 8 mL of 1.5 wt % silica nanoparticles in 
Milli-Q adjusted to pH 10) was 4.2 ± 1.2 µm as determined using microscopy image 
analysis.  As shown in Figure 5.7e, control studies performed without the crosslinking 
polymer in the oil phase formed structures with a core-shell morphology.  
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Figure 5.7: Confocal images of FITC-labeled nanoparticles with Nile Red loaded oil 
phase.  a) The green fluorescence channel shows the FITC-labeled silica nanoparticles 
are present at the surface and in the core of the composite.  b) Bright field image of the 
composite.  Inset shows composite size distribution.  c) Red fluorescence channel shows 
the Nile Red-loadedorganic phase containing limonene and crosslinking polymer  p-MA-
alt-1-OD .  d) The merged fluorescence image provides an overlay of  the co-localized 
green fluorescent nanoparticles with the red fluorescent oil core.  e) Merged fluorescence 
image of uncrosslinked Pickering emulsions, showing core-shell morphology.   
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The colocalization of the hydrophobic dye and nanoparticle fluorescence signals 
in Figure 5.7d suggested that structures distinct from core-shell Pickering emulsions were 
produced during the crosslinking step. Further demonstration of this morphological 
transition was provided using Z-stacked confocal microscopy (Figure 5.8) and optically 
cross-sectioning crosslinked microparticles immobilized in an agar medium. The polymer 
crosslinked structures displayed a 3D composite structure consistent with the images in 
Figure 5.7, where the nanoparticles (green) and Nile red containing oil are co-distributed 
throughout the composite as confirmed by the sequential series of optical slices in Figure 
5.8. 
 
Figure 5.8:  Confocal microscopy cross-sections of a composite structure.  Images were 
taken in 1 µm slices.  Green fluorescence from the nanoparticles and red fluorescence 
from the Nile red was colocalized in the oil core of the composite. 
 
Scanning electron microscopy (SEM) and transmission electron microscopy 
(TEM) were used to further study the structure of the composite and the morphological 
stability of these crosslinked composites under drying conditions.  SEM of the 
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crosslinked composites (2 mL 5 wt % p-MA-alt-1-OD in Limonene: 8 mL 1.5 wt % silica 
nanoparticles in Milli-Q water) dried from aqueous solution show silica nanoparticles 
densely packed into spherical structures (Figure 5.9a, b, Figure 5.10). TEM images show 
intact spheres that are in agreement with SEM results (Figure 5.9c, d).   
 
Figure 5.9: a,b) SEM images show densely packed silica nanoparticle and polymer 
composites.  c,d) TEM images of dried composites show intact spheres, studded with 
silica nanoparticles.  Composites were formed by emulsifying 2 mL of 5 wt % p-MA-alt-
1-OD in limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q water. 
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Figure 5.10:  Scanning electron microscopy image of dried composite structure.  Inset 
displays composite size distribution.  Composites have an average diameter of 2.3 ± 0.72 
µm.  Composites were generated by emulsifying 2 mL of 5 wt % p-MA-alt-1-OD in 
limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q adjusted to pH 10 for 2 
minutes at 24,000 RPM.   
Having established the morphology of the composites, we next focused on 
characterizing the chemical processes involved in the crosslinking step. Infrared 
attenuated total reflectance Fourier transform (ATR-FT-IR) spectroscopy was performed 
on the amine-functionalized silica nanoparticles, p-MA-alt-1-OD, and the crosslinked 
composites (2 mL of 12 wt % p-MA-alt-1-OD in limonene: 8 mL of 1.5 wt % silica 
nanoparticles in Milli-Q adjusted to pH 10) to confirm crosslinking between the 
nanoparticles and the polymer backbone (Figure 5.11).  The crosslinked composites 
displayed spectra in agreement with the absorbance spectra shown by both the 
nanoparticles and polymer individually.  The composites, however, showed a loss of the 
maleic anhydride peak and the formation of an absorbance at 1712 cm-1 attributed to the 
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carboxylic acid functionality arising from the ring opening of the maleic anhydride.  
Broad absorption around 2500 - 3250 cm-1 likewise supports formation of a carboxylic 
acid functional group.  
 
Figure 5.11:  ATR-FT-IR characterization of the silica nanoparticles, p-MA-alt-1-OD, 
and crosslinked composites after composite formation and freeze-drying.  Amine 
functionalized silica nanoparticles show characteristic peaks at 3280 cm-1, 1063 cm-1, and 
936 cm-1 attributed to the Si-O and Si-OH frequencies. Maleic anhydride frequencies at 
1856 cm-1 and 1774 cm-1 were identified in the polymer along with the octadecane at 
2920 cm-1 and 2851 cm-1.  The crosslinked composites possessed peaks at frequencies 
similar to both the nanoparticles and polymer.  The ring opening of the maleic anhydride 
in the polymer was confirmed by the appearance of a peak 1712 cm-1 and the loss of the 
peak at 1856 cm-1.  Broad absorption around 2500 - 3250 cm-1 is attributed to the 
presence of the generated carboxylic acid functionality.    
Further characterization of the crosslinking reaction was done by measuring the 
amount of remaining free amines on the surface of the nanoparticles after crosslinking.28  
The quantification was done through a modified ninhydrin reaction and the external 
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calibration curve shown in Figure 5.12.  The emulsions were generated through the 
emulsification of dichloromethane (to allow easy separation from the aqueous phase) 
with increasing amounts of dissolved polymer.  The emulsions were reacted overnight to 
ensure the ring opening reaction had gone to completion.  As shown in Figure 5.13, the 
amount of free amines decreases rapidly with increasing polymer concentrations, 
showing an almost complete reaction of the amines at higher polymer ratios.  Amine-
functionalized silica nanoparticles show 4 amines per square nanometer, in agreement 
with literature findings.28  As the amine functionalities present on the surface of the 
nanoparticles react with the polymer, the colorimetric reaction with ninhydrin is reduced.  
The amine groups are nearly fully crosslinked by 18 wt % p-MA-alt-1-OD in the oil 
phase, with a greater extent of crosslinking corresponding to a lower particle loading. 
 
Figure 5.12: Calibration curve used to quantify amines was generated using  
3-aminopropyltriethoxysilane (APS) and ninhydrin.  
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Figure 5.13: Remaining free amine concentration determined using a modified ninhydrin 
reaction with 2 silica loadings as a function of crosslinking polymer concentration. a) 
Amine-functionalized silica nanoparticles show 4 amines/nm2 are available for 
crosslinking, and amines are readily crosslinked by the polymer with near complete 
consumption of the functional groups by 18 wt % p-MA-alt-1-OD.  b) Expanded view of 
the near complete loss of amine functionality as polymer concentration increases.   
The extent of the crosslinking reaction was also examined as a function of pH 
(Figure 5.14, 5.15, 5.16). We hypothesized that an increase in maleic anhydride units 
within the oil would form more carboxylic acid units and decrease the pH of the system. 
To test this hypothesis, the polymer concentration in the oil phase was increased with the 
amount of silica held constant and the pH of the emulsified mixture was then monitored 
over time.  As expected, an increase in polymer concentration induces the pH of the total 
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system to lower.  The greatest degree of pH change was observed for the highest polymer 
loading of 15 wt % p-MA-alt-1-OD in the limonene oil phase with the pH after 
emulsification being reduced from 8.5 to 5.5.   Taken together, the IR results, the 
ninhydrin assay, and the generation of acid all support amine-anhydride crosslinking 
between the particles and polymer.  
 
Figure 5.14: Tracking crosslinking kinetics by monitoring the decrease in pH due to 
formation of carboxylic acid groups during crosslinking of amine-functionalized silica 
nanoparticles by p-MA-alt-1-OD polymer in the oil phase.  An increase in polymer 
concentration resulted in an appreciably lower pH once equilibrium was established, 
indicating that pH is a sensitive probe for reaction kinetics. 
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Figure 5.15: Plot of the decrease in pH over time with varying amounts p-MA-alt-1-OD 
in limonene.  Composites were generated by emulsifying 2 mL of varying wt % p-MA-
alt-1-OD in limonene into 8 mL of 0.5 wt % silica nanoparticles in Milli-Q adjusted to 
pH 10 for 2 minutes at 24,000 RPM.  The reactions were measured by immersing a pH 
probe into the solution following emulsification.   
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Figure 5.16: Plot of the decrease in pH over time with varying amounts p-MA-alt-1-OD 
in limonene.  Composites were generated by emulsifying 2 mL of varying wt % p-MA-
alt-1-OD in limonene into 8 mL of 1.0 wt % silica nanoparticles in Milli-Q adjusted to 
pH 10 for 2 minutes at 24,000 RPM.  The reactions were measured by immersing a pH 
probe into the solution following emulsification.   
 
5.2.3. Stability of Composites 
To determine robustness and durability, the crosslinked composites were stored 
for one month.  Figure 5.17a shows the composites prior to storage.  After storage for one 
month, the composites do not undergo visible phase separation, indicating effective 
entrapment of the oil within the hybrid matrix.  Additionally, the average size of the 
composites does not change significantly as shown in Figure 5.17b, though some change 
in distribution is observed.  Although the composites creamed over time, this is attributed 
to the lower density, 0.8411 g/mL, of the limonene core compared to the continuous 
aqueous phase and is not indicative of leakage or instability (Figure 5.18).  Polymer 
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loading did not significantly alter the particle size distributions of the resulting 
assemblies. 
 
Figure 5.17: a) Bright field image of composites prior to storage.  Inset shows distribution 
of composite sizes determined by image analysis.  Composites had an average diameter 
of 4.2 ± 1.2 µm.  b)  Bright field image of composites after one month of storage.  Inset 
shows distribution of composite size.  Composites had an average diameter of 4.5 ± 1.5 
µm. 
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Figure 5.18: Image of the composites with varying wt. % of polymer dissolved in the 
limonene phase after one month of storage.  Composites were generated by emulsifying 2 
mL of varying wt % p-MA-alt-1-OD in limonene into 8 mL of 1.5 wt % silica 
nanoparticles in Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.  Composite 
were sealed and stored for one month at room temperature. 
 
5.2.4. Payload release by the crosslinked composites 
Based on the structural studies above, we postulated that these materials should 
behave as porous 'sponges', retaining payload in competitive environments without 
dissociating. To test this possibility, we explored the release of payload from the 
nanocomposites in ethanol, using diphenyl ether as a tracer molecule.  Diphenyl ether 
was chosen as an appropriate tracer due to its closely matching logP value of 4.21 
compared to 4.23 for limonene.  The addition of diphenyl ether (13 wt %) to the limonene 
did not affect the overall structure of the composite as determined by optical microscopy 
(Figure 5.19).  There was no change in composite size upon incubation with ethanol as 
observed by optical microscopy, demonstrating the stability of these systems in an 
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environment of intermediate polarity (Figure 5.20).  To quantify the leaching of payload 
in a model competitive medium, the composites were incubated for one hour in absolute 
ethanol.  The composites were subsequently centrifuged and the UV-absorbance spectra 
of the supernatant was recorded to quantify release.  As expected, an increase in polymer 
concentration increases the crosslinking density thereby reducing oil release, with 
capsules containing 5 wt % of polymer in the oil phase displaying maximum payload 
retention (Figure 5.21).  At higher polymer concentrations, there was no additional 
payload retention, consistent with the complete reaction of the surface amines found in 
the ninhydrin assay.  These results further support the hypothesis that the increasing 
number of covalent nanoparticle-polymer bonds reduces the permeability through the 
composite matrix.  
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Figure 5.19: Bright field microscopy images of composites generated with increasing 
polymer loadings in the oil phase used for release quantification.  Composites were 
generated by emulsifying 2 mL of varying wt % p-MA-alt-1-OD in a 13 % v/v mixture of 
diphenyl ether in limonene into 8 mL of 1.5 wt % silica nanoparticles in Milli-Q adjusted 
to pH 10 for 2 minutes at 24,000 RPM.   
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Figure 5.20: Bright field image of composites incubated with ethanol.  Inset displays 
composite size distribution.  Composites had an average diameter of 4.4 ± 0.9 µm.  
Composites were generated by emulsifying 2 mL of 5 wt % p-MA-alt-1-OD in a 13 % 
v/v mixture of diphenyl ether in limonene into 8 mL of 1.5 wt % silica nanoparticles in 
Milli-Q adjusted to pH 10 for 2 minutes at 24,000 RPM.   
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Figure 5.21: Release of diphenyl ether tracer from composites as a function of wt. % 
polymer dissolved in the limonene oil phase.  Greater tracer retention was achieved by 
higher polymer loadings.  The control capsules generated with the individual components 
showed complete release of payload.  The curve was drawn to assist the eye.   
 
5.3. Conclusions 
We have shown that amine functionalized silica nanoparticles and maleic 
anhydride copolymers form stable size-controlled organic-inorganic hybrid composites 
from an oil/water emulsion template.  Due to the alternating structure of the hydrophobic 
polymer used for the crosslinking, we hypothesize that this inside-out crosslinking 
method extensively connects the nanoparticles and alters the nanoparticles 
hydrophobicity at the oil/water interface, with the nanoparticles pulled into the oil core as 
their surfaces become more hydrophobic.  These hybrid composites showed considerable 
resistance to the generally interface disrupting influence of ethanol.  Future experiments 
will explore tuning the porosity of the structure through modification of the component 
precursors.  The ability to parametrically vary the polymeric and inorganic components to 
tune the release behavior without greatly altering the vehicle’s size is a particular 
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advantage over other porous delivery vehicles.  These systems will also be probed for 
their effectiveness in multicomponent fragrance formulations and their ability to 
incorporate biomolecules into the composite structure for delivery and catalytic 
applications.  Moreover, this Pickering emulsion-based strategy provides a potentially 
generalizable strategy to generate in situ reservoirs of hydrophobic molecules for 
multiple controlled release and delivery applications.   
5.4. Experimental Methods 
5.4.1. Materials 
Tetraethyl orthosilicate (purity of 99%), 3-aminopropyl triethoxysilane (purity of 99%), 
ammonium hydroxide (28% ACS Plus), sodium hydroxide (purity of 97%), Nile Red 
(purity of 99%), fluorescein isothiocyanate isomer I (purity of 90%), agar (granulated, 
Fisher BioReagentsTM), diphenyl ether (purity of 99%), and 200 proof ethanol were 
purchased from Fisher Scientific and used as received.  Poly(maleic anhydride-alt-1-
octadecene) (p-MA-alt-1-OD; average Mn of 30,000-50,000) was purchased from Sigma-
Aldrich and used as received.  Limonene was provided by Firmenich Inc.  Milli-Q water 
with a resistivity of 18.2 MΩ∙cm was used for all experiments. 
5.4.2. Synthesis and Functionalization of Silica Nanoparticles 
The silica nanoparticles were synthesized using an adapted Stober method.26  Briefly, to 
synthesize 150 nm amine functionalized silica nanoparticles, 24 mL of ammonium 
hydroxide were added to 300 mL of absolute ethanol and stirred for five minutes in a 500 
mL round-bottom flask. Then 12 mL of tetraethyl orthosilicate were added to the reaction 
flask and stirred overnight at room temperature.  To functionalize the surface of the 
nanoparticles, 1.22 mL of 3-aminopropyl triethoxysilane were added and the reaction was 
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stirred for an additional 24 hours. The nanoparticles were purified by centrifuging and re-
dispersing in water and ethanol (3x each). The washed silica nanoparticles were 
lyophilized and used in powdered form.  The nanoparticles had an average diameter of 
150 ± 13 nm determined by transmission electron microscopy (TEM) and 165.1 ± 3.5 nm 
determined by dynamic light scattering (DLS), (Figure 5.22, 5.23). The nanoparticles had 
a zeta potential of +16.3 ± 3.6 mV in 5 mM sodium phosphate buffer (pH = 7.4), (Figure 
5.24).  Synthesis of fluorescein labeled nanoparticles27 was performed following a similar 
method wherein 5.25 mg of fluorescein isothiocyanate were reacted with 69.0 mg of 3-
aminopropyl triethoxysilane in one mL of absolute ethanol under nitrogen overnight. This 
fluorescent conjugate mixture was added to the nanoparticle reaction solution 5 minutes 
after the addition of tetraethyl orthosilicate.  The procedure then proceeded as described 
above.  
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Figure 5.22: Transmission electron microscopy image of silica nanoparticles used 
throughout the study.  Nanoparticles had an average diameter of 154 ± 13 nm. 
 
 
Figure 5.23: Average diameter by number of silica nanoparticles in MilliQ water as 
determined by dynamic light scattering was 165.1 ± 3.5 nm. 
 
Figure 5.24: The average zeta potential of the silica nanoparticles was 16.3 ± 3.64 mV in 
5 mM phosphate buffer adjusted to pH 7.4. 
5.4.3. Microscopy and Particle Characterization   
TEM samples were prepared on 300 square mesh nickel grids with Formvar film 
purchased from Electron Microscopy Sciences.  TEM images were acquired on a JEOL 
100CX operating at 100 keV.  Scanning electron microscopy (SEM) data were obtained 
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using a FEI Magellan 400 field emission scanning electron microscope operated at 1.0 
kV with 13 µA of beam current. Samples were prepared by drying diluted sample onto a 
boron-doped Si wafer purchased from WRS Materials. DLS data were measured with a 
Malvern Zetasizer Nano ZS.  Optical and fluorescence images of the capsules were taken 
on an Olympus IX51 microscope.  Confocal experiments were performed on a Zeiss 
LSM510 meta confocal microscope.  Nile Red, a lipophilic fluorophore, was loaded into 
the oil phase at 0.05 wt. % to facilitate fluorescence microscopy.  For the z-stack images 
the capsules were diluted into a 0.5 % w/w agar in water solution to reduce the Brownian 
motion of the matrix microparticles.  ImageJ software was used to determine average 
diameters of composites for all microscopy methods. 
5.4.4. Emulsification 
Emulsions were generated using an IKA T 25 digital ultra-turrax disperser with an S25N-
10G dispersing element. The 20 % v/v oil in water emulsions were made by emulsifying 
2 mL of hydrophobic oil containing the hydrophobic polymer into 8 mL of pH 10 
adjusted water with dispersed 150 nm amine functionalized silica nanoparticles at a 
homogenization speed of 24,000 RPM for two minutes. The as-formed emulsions were 
allowed to react for one day before characterization. 
The formulation used for characterization unless otherwise specified was 2 mL of 5 wt % 
p-MA-alt-1-OD in limonene emulsified into 8 mL of 1.5 wt % silica nanoparticle solution 
in Milli-Q adjusted to pH 10. 
5.4.5. ATR-FT-IR of Silica Nanoparticles, Polymer, and Freeze-dried Crosslinked 
Composite   
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IR was performed on a Bruker Alpha FT-IR spectrophotometer fitted with a Platinum 
ATR QuickSnap sampling module. The silica nanoparticles and polymer were analyzed 
as neat solids. The crosslinked composites were freeze-dried in order to obtain a dry solid 
that was analyzed in the same fashion. 
5.4.6. Ninhydrin Assay for Amine Quantification  
One mL of the crosslinked nanoparticle-stabilized composite solution was added to one 
mL of the generated stock ninhydrin solution (0.35 w/v % in pure ethanol) in a 7 mL 
glass vial and sealed. The vial was heated for 60 seconds; thereafter a blue/purple color 
was obtained. The vial was centrifuged at 14,000 rpm for 20 minutes, the supernatant was 
transferred to a cuvette, and the absorbance at 588 nm was recorded. This absorbance was 
compared to a generated calibration curve using 3-aminopropyl triethoxysilane and 
ninhydrin to determine the amount of free amine.28  
5.4.7. Release Studies   
Diphenyl ether was selected to be a tracer within the limonene core.  The hydrophobic oil 
comprised 13 wt. % of diphenyl ether in limonene, and emulsions were formed in the 
same fashion as previously described. After the emulsions were allowed to react for one 
day, 100 µL of the emulsion slurry were incubated in 4 mL of absolute ethanol for one 
hour. The absorbance of the solution at 270 nm (the observed maximum absorbance of 
diphenyl ether) was recorded.  A calibration curve was generated and used to determine 
the amount of diphenyl ether released into the ethanol. 
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CHAPTER 6 
NANOPARTICLE STABILIZED CAPSULES FOR THE TREATMENT OF 
BACTERIAL BIOFILMS 
6.1. Introduction 
Bacterial biofilms are highly resilient microbial assemblies that are difficult to 
eradicate.1  These robust biofilms frequently occur on synthetic implants and indwelling 
medical devices including urinary catheters,2 arthro-prostheses,3 and dental implants.4  
Biofilm proliferation can also occur on dead or living tissues, leading to endocarditis,5 
otitis media,6 and chronic wounds.7  The persistent infections and their concomitant 
diseases are challenging to treat, as biofilms develop a high resistance to host immune 
responses and the extracellular polymeric substances limit antibiotic penetration into 
biofilms.8,9  Current techniques to remove biofilms on man-made surfaces include 
disinfecting the surface with bleach or other caustic agents.10  Biofilms in biomedical 
contexts are very challenging, with therapies based on excising infected tissues combined 
with long-term antibiotic therapy, incurring high health care costs and low patient 
compliance due to the invasive treatment.11  This issue is exacerbated by the exponential 
rise in antibiotic resistant bacteria.12 
Phytochemicals have emerged as an promising alternative to traditional 
antimicrobials to treat antibiotic resistant bacteria.13,14 These essential oils and natural 
compounds are of particular interest as “green” antimicrobial agents due to their low-
cost, biocompatibility, and potential anti-biofilm properties.15,16,17  The generally poor 
aqueous solubility and stability of these oils has substantially limited their widespread 
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application.18   Engineering nanomaterials provides a potential platform to prevent 
payload degradation and to tune molecular interactions with bacteria.19,20,21,22  Previous 
reports have shown that encapsulating essential oils into surfactant-stabilized colloidal 
delivery vehicles improves their aqueous stability and increases the antimicrobial activity 
of small molecule payloads.23,24,25  However, these carriers often induce adverse 
hemolytic or irritating effects restricting their compatibility with biological tissues.26,27  
Pickering emulsions provide an analogous route to encapsulate hydrophobic molecules 
within a self-assembled colloidal shell that is highly resistant to coalescence.28,29   The 
multivalent nanoparticles embedded at the oil/water interface can also be post-
functionalized to create structurally diverse carriers not achievable when using surfactant 
stabilized emulsions.30,31 
Herein, we describe the fabrication of a multifunctional essential oil-based 
Pickering emulsion for the treatment of bacterial biofilms.  The self-assembly strategy 
relies on hydrophobic phytochemicals playing both antimicrobial and structural roles for 
the drug delivery vehicle.  Peppermint oil droplets provide the main hydrophobic core 
template for nanoparticle assembly.  Dissolved cinnamaldehyde plays a dual role within 
the oil core by covalently reacting with the nanoparticles at the interface to modify the 
shell of the capsules from within and acting as a potent antimicrobial agent once 
delivered into the biofilm.  These microcapsules effectively eradicate both laboratory and 
pathogenic biofilms.  The inclusion of cinnamaldehyde also enhanced fibroblast 
proliferation32 promoting therapeutic behavior of the capsules as demonstrated in an in 
vitro co-culture model. This work presents a versatile colloidal strategy for 
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multicomponent essential oil formulations with potential use as a general topical 
antimicrobial and disinfectant.   
6.2. Results and Discussion 
6.2.1. Generation and characterization of capsules 
Silica nanoparticles (SiO2 NPs) were chosen to stabilize the emulsions as they are 
biocompatible, surface functionalization can be easily introduced, and their diameters can 
be readily tuned.31,33,34  Control over the size is especially important as nanomaterials 
smaller than 70 nm have been shown to readily penetrate the skin causing detrimental 
side-effects.35,36,37  Therefore, we synthesized cationic amine-functionalized SiO2 NPs 
with an average diameter of ~150 nm. (Figure 6.1, 6.2, 6.3)  Antimicrobial capsules were 
generated using a Pickering emulsion template as shown in Figure 6.4.  Capsules were 
created by emulsifying either peppermint oil or a mixture of cinnamaldehyde dissolved in 
peppermint oil into MilliQ H2O adjusted to a pH of 10 containing the nanoparticles.  The 
nanoparticles self-assemble at the oil/water interface to stabilize the peppermint oil 
droplets.  Surface amines on the nanoparticles then react with the cinnamaldehyde within 
the oil phase.  Silica loadings in the aqueous phase were varied to determine the amount 
needed to minimize capsule dispersity.  At loadings above of 1.2 wt. % SiO2 NPs or 
greater, capsules were found to have a minimum dispersity and therefore this amount was 
chosen for all further studies. (Figure 6.5)  It was also observed that capsules generated 
with higher than 5 % v/v cinnamaldehyde were unstable which corresponds to 52-fold 
excess of cinnamaldehyde to available amines on the nanoparticle surface.  (Figure 6.6)  
These peppermint oil based capsules (P-Cap) and capsules containing 5 % v/v of 
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cinnamaldehyde dissolved in peppermint oil (CP-Cap) were found to have average 
diameters of 6.8 ± 1.9 µm and 6.7 ± 1.9 µm, respectively. (Figure 6.7) 
 
 
Figure 6.1: Transmission electron microscopy (TEM) image of silica nanoparticles.  The 
nanoparticles had an average diameter of 152 ± 15 nm.  Inset is a histogram of the 
measured nanoparticle diameters.  Scale bar is 500 nm. 
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Figure 6.2: Average diameter of the silica nanoparticles in MilliQ H2O was determined to 
be 171.5 ± 2.8 nm by dynamic light scattering (DLS).   
 
 
 
Figure 6.3: Zeta potential of the silica nanoparticles in 5 mM sodium phosphate buffer 
adjusted to pH 7.4 was found to be 16.7 ± 0.1 mV. 
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Figure 6.4: a) Schematic depiction of the strategy used to generate antimicrobial capsules.  
Peppermint oil with dissolved cinnamaldehyde is emulsified into an aqueous suspension 
of amine functionalized silica nanoparticles.  Cinnamaldehyde within the oil reacts with 
the amines on the nanoparticles at the oil/water interface to create a multimodal delivery 
vehicle.  b) Capsules interact with biofilm through electrostatic complementarity.  
Capsules release their payload disrupting the biofilm, eliminating the bacteria.  
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Figure 6.5: Optical microscopy images of P-Caps with increasing amounts of silica 
loading.  P-Caps were generated using aqueous phases comprised of a) 0.3 wt. % silica 
(average diameter = 6.1 ± 3.0 µm), b) 0.6 wt. % silica (average diameter = 7.1 ± 3.0 µm), 
c) 0.9 wt. % silica (average diameter = 6.7 ± 2.1 µm), d) 1.2 wt. % silica (average 
diameter = 6.5 ± 1.7 µm), and e) 1.5 wt. % silica (average diameter = 6.6 ± 2.1 µm), 
respectively.  Insets are histograms of the capsule diameter measurements.  Scale bars are 
50 µm.  f) Box plot of the P-Caps at various silica loadings demonstrating capsule 
dispersity minimizes with increasing wt. % of silica.   
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Figure 6.6: Capsules generated with increasing concentrations of cinnamaldehyde.  
Capsules were generated by adding 300 µL of peppermint oil or a cinnamaldehyde-
peppermint oil mixture to 1.2 mL of MilliQ H2O adjusted to a pH of 10 containing 1.2 
wt. % of silica nanoparticles and emulsifying for 50 seconds. 
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Figure 6.7: Optical microscopy images of a) P-Cap and b) CP-Cap.  P-Cap had an 
average diameter of 6.8 ± 1.9 µm and CP-Cap had an average diameter of 6.7 ± 1.9 µm.  
Insets are histograms of the capsule diameter measurements.  Scale bars are 50 µm.  
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We used confocal microscopy, X-ray photoelectron spectroscopy (XPS), 
attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), and 
contact angle goniometry to probe the cinnamaldehyde-nanoparticle interaction.  
Reactive molecules within the oil core of Pickering emulsions have been previously 
demonstrated to affect capsule morphologies by modulating the hydrophobicity of the 
nanoparticles.38,39  To determine if structural reorganization occurs with our mixed oil 
system, capsules were generated using a Nile red loaded oil core and nanoparticles 
possessing cores labeled with fluorescein isothiocyanate (FITC).  As shown in Figure 
6.8a, b, and Figure 6.9, both capsules with and without cinnamaldehyde possess core-
shell morphologies.  This result indicates that the 5 % v/v loading of cinnamaldehyde into 
the peppermint oil does not alter the capsule structure.     
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Figure 6.8: Confocal micrographs of a) P-Cap and b) CP-Cap.  The nanoparticles’ cores 
are labeled with fluorescein (green fluorescence) and the oil phases are loaded with Nile 
red (red fluorescence).  Scale bars are 20 μm.  c) XPS spectra showing N 1s core levels 
arising from SiO2 NPs and CP-Cap.  d) Water contact angles of silica nanoparticles 
following incubation with varying concentrations of cinnamaldehyde. 
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Figure 6.9: Confocal microscopy images of a) P-Cap and b) CP-Cap.  The nanoparticles’ 
cores are labeled with fluorescein (green fluorescence) and the oil phases are loaded with 
Nile red (red fluorescence).  Scale bars are 10 μm.   
 
We next used XPS and ATR-FTIR to elucidate the reactivity of the nanoparticles 
with the dissolved cinnamaldehyde of the capsules.  Prior to analysis, CP-Caps were 
disrupted with ethanol, centrifuged, and lyophilized to remove any adsorbed 
cinnamaldehyde.  The Schiff base of 3-aminopropyltriethoxysilane and cinnamaldehyde 
was also synthesized for comparison. (Figure 6.10)  As shown in Figure 6.8c, the SiO2 
NPs showed two chemically distinct species with a lower binding energy (BE) 
component at ca. 399.5 eV and a higher BE component at ca. 401.8 eV.  These 
correspond to amine (-NH-) and protonated amine (NH3
+) present on the surface of SiO2 
NPs that is consistent with previously reported values.40  The N 1s spectra of CP-Cap 
shows three distinct chemical species.  In addition to the two N 1s BE components 
observed in the SiO2 NPs, a new peak centered at ca. 400.1 eV indicates the formation of 
an imine functional (-C=N-) group which corroborates well with literature values.41  The 
N 1s spectra from the synthesized Schiff base showed a single chemically distinct N 1s 
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species centered at ca. 400.2 eV, which corresponds to the imine functional group (-C=N-
).41  Similarly, the chemically distinct species of the C 1s spectra obtained from CP-Cap 
matches well with the synthesized Schiff base further providing evidence on the covalent 
linkage of the amine and cinnamaldehyde (Figure 6.11).  Additionally, the Si 2p and O 1s 
peak shows typical BEs centered at ca. 103.2 eV and 532.6 eV, respectively that matches 
with reported values for SiO2 NPs (Figure 6.11).
42  ATR-FTIR analysis further supported 
the formation of the cinnamaldehyde Schiff base (Figure 6.12). 
 
Figure 6.10: 400 MHz 1H NMR spectrum of the Schiff base, 3-phenyl-N-(3-
triethoxysilylpropyl)prop-2-en-1-imine, in chloroform-D (D-99.8 %).  Spectrum was 
obtained on a Bruker Avance 400 MHz, 16 scans. 
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Figure 6.11: XPS spectra of a) amine functionalized SiO2 NPs, b) CP-Caps, and c) Schiff 
base.   
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Figure 6.12: ATR-FT-IR characterization of cinnamaldehyde, the cinnamaldehyde-silane 
Schiff base, the silica nanoparticles, and CP-Caps after freeze drying.  Cinnamaldehyde 
displayed characteristic peaks at 1667 cm−1 and 1624 cm−1 attributed to the C=O and 
C=C frequencies.  The Schiff base possessed peaks at 1681 cm−1 and 1633 cm−1 
attributed to C=N and C=C bonds, respectively.  The Schiff base also displayed peaks at 
1102 cm−1 and 1006 cm−1 attributed to the Si-O and Si-OEt frequencies.  Amine-
functionalized silica nanoparticles showed characteristic peaks at 1080 cm−1 and 947 
cm−1 attributed to the Si-O and Si-OH frequencies.  CP-Caps displayed peaks at 
frequencies similar to the SiO2 NPs and the Schiff base confirming the formation of the 
Schiff base complex on the nanoparticles. 
 
An in situ covalent reaction of the primary amine groups on the nanoparticles 
with cinnamaldehyde should alter the hydrophobicity of the nanoparticle surface 
improving the stabilization behavior of the Pickering emulsifiers.43  Contact angle 
goniometry was used to measure the change in nanoparticle hydrophobicity.  
Nanoparticles were deposited onto silicon wafers and briefly incubated in 
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dichloromethane solutions with varying amounts of dissolved cinnamaldehyde.  The 
surfaces were then rinsed with dichloromethane, dried, and the water contact angles were 
obtained. (Figure 6.13)  Figure 6.8d shows that as the percentage of cinnamaldehyde by 
volume increases from 0 % to 5 %, the water contact angle of the nanoparticles increases 
from 31° to 49°.  This increase in water contact angle, taken together with the XPS data, 
the ATR-FTIR data, and confocal images, indicates that the inclusion of cinnamaldehyde 
within the peppermint oil core generates a distinct, multi-component capsule structure.   
 
Figure 6.13: Representative digital images of water droplets used to determine contact 
angles.  
 
6.2.2. Capsule penetration into the biofilms 
Biofilms produce extracellular polymeric substances that prevent effective 
delivery of therapeutics.44  Having established that the capsules have core-shell 
morphologies and the cinnamaldehyde is successfully incorporated into the capsules, we 
set out to determine whether these capsules could effectively penetrate into biofilms.  
Using fluorescently labeled nanoparticles to track the delivery of the emulsions, we 
treated biofilms from E. coli that had been modified to express E2-Crimson, a far-red 
fluorescent protein.  As shown in Figure 6.14, both P-Cap and CP-Cap diffuse into the 
biofilm matrix and efficiently disperse throughout the biofilm whereas the unassembled 
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nanoparticles displayed minimal penetration.  These data indicate the capsules deliver 
their payload in a burst release fashion and that both the oil core and nanoparticle shell 
are operative for effective delivery.   
 
Figure 6.14: Representative 3D projection of confocal image stacks of 1 day-old E. coli 
DH5α biofilm after 3 hrs treatment with a) CP-Cap containing FITC-labeled SiO2 NP, b) 
P-Cap containing FITC-labeled SiO2 NP, and c) FITC-labeled SiO2 NP at 20 % (v/v % 
of 2 % emulsion) concentration.  Upper panels are projection at 247° angle turning along 
Y axis and lower panels are at 270° angle turning along Y axis. Scale bars are 20 μm. 
 
6.2.3. Antimicrobial activity of capsules against biofilms 
Next, we investigated the therapeutic behavior of the capsules against established 
bacterial biofilms.  One laboratory strain, E. coli DH5α, and 3 pathogenic bacteria strains 
of clinical isolates, P. aeruginosa (CD-1006), S. aureus (CD-489, a methicillin-resistant 
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strain), and E. cloacae complex (CD-1412),  were chosen to test our system.  As shown in 
Figure 6.15, both the CP-Cap and P-Cap vehicles effectively were able to kill bacteria 
cells in all four biofilms, with CP-Cap possessing greater activity.  The capsules 
demonstrated a dramatically enhanced efficacy compared with the unencapsulated oil, 
supporting the hypothesis that the cationic nanoparticle shell of the capsules increases 
interaction with the biofilms.45  In addition, the acidic pH of the biofilm environment46 
should promote the hydrolysis of Schiff bases, enhancing the sustained release of 
cinnamaldehyde.  These capsules were able to treat both Gram negative (E. coli, P. 
aeruginosa, and E. cloacae complex) and Gram positive (S. aureus) bacteria.  Notably, 
the capsules demonstrated a similar efficacy against the multi-drug resistant S. aureus 
stain when compared to the non-resistant strains, supporting that these capsules present a 
viable treatment alternative to traditional antibiotics.   
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Figure 6.15: Viability of 1 day-old a) P. aeruginosa (CD-1006)  b) E. coli DH5α c) S. 
aureus (CD-489) d) E. cloacae complex (CD-1412) biofilms after 3 hrs treatment with 
CP-Cap, P-Cap, SiO2 NP, and peppermint oil at different emulsion concentrations (v/v % 
of 2 % emulsion). The data are average of triplicates and the error bars indicate the 
standard deviations. 
 
6.2.4. Co-culture treatment of biofilms 
Biofilm infections within wounds interfere with the ability of the host to 
regenerate damaged tissue.47  Fibroblasts in particular play a vital role in the wound 
healing process, helping to close the injury and redevelop the extracellular matrix within 
the skin.48,49  We used an in vitro co-culture model comprised of mammalian fibroblasts 
and a biofilm to determine whether our capsules could successfully treat a biofilm in the 
presence of host cells. 50   E. coli DH5α bacteria were seeded with a confluent NIH 3T3 
fibroblast cell monolayer overnight to generate biofilms prior to treatment.  The co-
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cultures were treated with capsules for 3 hrs, washed, and the viabilities of both 
fibroblasts and bacteria were measured.  As shown in Figure 6.16, CP-Cap effectively 
treated the biofilm infection whereas P-Cap and the controls did not.  The capsule 
structure also prevented the toxic effects shown by the unencapsulated peppermint oil to 
the fibroblasts.  Notably, CP-Cap enhanced 3T3 cell growth in agreement with studies 
that cinnamaldehyde can promote insulin-like growth factor-I signaling, increasing cell 
proliferation.32    
 
Figure 6.16: Viability of 3T3 fibroblast cells and E. coli biofilms in the co-culture model 
after 3 hrs treatment with a) CP-Cap, b) P-Cap, c) SiO2 NP, and d) peppermint oil at 
different emulsion concentrations (v/v % of 2 % emulsion). Scatters and lines represent 
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3T3 fibroblast cell viability. Bars represent log10 of colony forming units in biofilms. The 
data are average of triplicates and the error bars indicate the standard deviations.  
6.3. Conclusions 
In summary, we report the development of a multimodal antimicrobial delivery 
vehicle.  The nanoparticle stabilized capsules demonstrated highly effective therapeutic 
behavior, successfully eradicating pathogenic biofilm strains of clinical isolates.  
Furthermore, the capsules effectively eliminated a biofilm infection while promoting 
fibroblast viability in an in vitro co-culture model.  Future studies will probe capsule 
performance in combating in vivo biofilms.   These capsules have potential applications 
as a general surface disinfectant as well as an antiseptic for wound treatment.  The 
reactive self-assembly based strategy provides a promising platform to create effective 
delivery vehicles to combat bacterial biofilms. 
6.4. Experimental Methods 
6.4.1. Materials 
All reagents/materials were purchased from Fisher Scientific and used as received.  
Boron-doped Si wafers were purchased from WRS Materials. NIH-3T3 cells (ATCC 
CRL-1658) were purchased from ATCC.  Dulbecco's Modified Eagle's Medium 
(DMEM) (DMEM; ATCC 30-2002) and fetal bovine serum (Fisher Scientific, 
SH3007103) were used in cell culture.  Pierce LDH Cytotoxicity Assay Kit was 
purchased from Fisher Scientific.   
6.4.2. Synthesis of Silica Nanoparticles 
Silica nanoparticles were synthesized according to the reported procedure.33,38  Briefly, to 
synthesize 150 nm amine functionalized silica nanoparticles, 24 mL of ammonium 
hydroxide were added to 300 mL of absolute ethanol and stirred for five minutes in a 500 
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mL round-bottom flask. Then 12 mL of tetraethyl orthosilicate were added to the reaction 
flask and stirred overnight at room temperature.  To functionalize the surface of the 
nanoparticles, 1.22 mL of 3-aminopropyl triethoxysilane were added and the reaction was 
stirred for an additional 24 hours. The nanoparticles were purified by centrifuging and re-
dispersing in water and ethanol (3x each).  
Synthesis of fluorescein labeled nanoparticles51 was performed following a similar 
method wherein 5.25 mg of fluorescein isothiocyanate were reacted with 69.0 mg of 3-
aminopropyl triethoxysilane in one mL of absolute ethanol under nitrogen overnight. This 
fluorescent conjugate mixture was added to the nanoparticle reaction solution 5 minutes 
after the addition of tetraethyl orthosilicate.  The procedure then proceeded as described 
above.  
6.4.3. Transmission Electron Microscopy (TEM) 
TEM samples were prepared on 300 square mesh nickel grids with Formvar film 
purchased from Electron Microscopy Sciences.  TEM images were acquired on a JEOL 
100CX operating at 100 keV.   
6.4.4. Dynamic Light Scattering (DLS) 
DLS experiments and zeta potential measurements were performed using a Malvern 
Zetasizer Nano ZS.  Samples were sonicated prior to measurements. 
6.4.5. Preparation of Capsules  
Stock capsules solutions were prepared in 1.5 mL Eppendorf tubes.  To prepare the stock 
P-Cap emulsions, 300 µL of peppermint oil was added to 1.2 mL of a 1.2 % wt. solution 
of SiO2 NPs in MilliQ H2O adjusted to pH 10 and was emulsified in an amalgamator for 
50 seconds.  To prepare the stock CP-Cap emulsions, 15 µL of cinnamaldehyde was 
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dissolved in 285 µL of peppermint oil prior to emulsification as described.  The 
emulsions were allowed to rest overnight prior to use.   Optical images of the capsules 
were taken on an Olympus IX51 microscope.   
6.4.6. Synthesis of Schiff Base 
Cinnamaldehyde (3.8 mL, 30 mmol) was dissolved in 150 mL of toluene and 3-
aminopropyl triethoxysilane (7.0 mL, 30 mmol) was added to the stirring reaction.  The 
flask was then equipped with a Dean-Stark trap, heated to 110 °C, and stirred overnight.  
After the reaction was complete (monitored by water volume collected in Dean-Stark 
trap), the mixture was cooled to room temperature and the solvent removed under 
reduced pressure.  The crude product was dissolved in dichloromethane and filtered to 
remove brown precipitates.  The filtrate was dried over anhydrous sodium sulfate and the 
dichloromethane was removed under reduced pressure.  The product was obtained as an 
amber colored oil, yield = 8.78 g, 87 %. 
6.4.7. XPS Determination of Cinnamaldehyde Reaction 
To determine whether cinnamaldehyde reacted with the surface amines of the 
nanoparticle, 500 µL of CP-Cap with 5 % v/v of cinnamaldehyde were diluted into 1.0 ml 
of ethanol.  Capsules were then broken by sonicating for 5 minutes and centrifuging at 
14,000 rpm to release all unreacted cinnamaldehyde.  Capsule were redispersed in 
ethanol, sonicated, and centrifuged three times to completely remove the oil phase.  The 
CP-Cap pellet was then freeze dried in order to obtain a dry solid for analysis. 
Samples were prepared by drop-casting the sample on a 100 nm gold-coated silicon 
substrate. XPS measurements were carried out using Physical Electronics Quantum 2000 
spectrometer at a pressure below 1×10–9 Torr.  The survey scan, C 1s, N 1s, O 1s and Si 
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2p core level spectra for all samples were recorded with un-monochromatized Al Kα 
radiation (photon energy of 1486.6 eV) at a pass energy of 46.95 eV and electron takeoff 
angle of 15°.  The overall resolution was 0.2 eV for the XPS measurements.  Chemically 
distinct species were resolved using a Gaussian-Lorentzian function with non-linear least-
square fitting procedure. All XPS spectra were background corrected using the Shirley 
algorithm and aligning the elemental binding energies to the adventitious carbon (C1s) 
binding energy of 284.6 eV.42 
6.4.8. ATR-FT-IR Determination of Cinnamaldehyde Reaction  
IR was performed on a Bruker Alpha FT-IR spectrophotometer fitted with a Platinum 
ATR QuickSnap sampling module.  Cinnamaldehyde was analyzed as a pure liquid.  The 
silica nanoparticles and Schiff base were analyzed as neat solids.  The CP-Caps were 
dissolved in ethanol, sonicated, and centrifuged three times to remove the oil phase.  The 
CP-Cap pellet was then freeze dried in order to obtain a dry solid that was analyzed. 
6.4.9. Contact Angle Goniometry 
Samples were prepared by immersing a clean silicon wafer (1 cm x 1 cm) into 1 mL of a 
1.2 % wt. solution of SiO2 NPs in MilliQ H2O adjusted to pH 10 for 5 minutes.  Wafers 
were then washed with MilliQ H2O to removed excess nanoparticles and dried under a N2 
stream.  Samples were then incubated in 1 mL solutions of dichloromethane with varying 
amounts (0, 1, 2, 5 % v/v) of dissolved cinnamaldehyde for 5 minutes.  Wafers were then 
washed with dichloromethane and dried under a N2 stream.  Static water contact angles 
were measured using a VCA Optima surface analysis/goniometry system with water 
droplets size of 2 µL. 
6.4.10. Biofilm Formation 
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Biofilms were grown as previously reported.50  Bacteria were inoculated in lysogeny 
broth (LB) medium at 37 °C until stationary phase. The cultures were then harvested by 
centrifugation and washed with 0.85 % sodium chloride solution three times. 
Concentrations of resuspended bacterial solution were determined by optical density 
measured at 600 nm. LB medium was supplemented with 0.1 % glucose, 1 mM MgSO4, 
0.15 M ammonium sulfate, and 34 mM citrate and buffered to pH 7 to ensure bacterial 
adherence to the microplate.  Seeding solutions were then made in this modified LB 
medium to reach an OD600 of 0.1.  A 100 μL amount of the seeding solutions was added 
to each well of the 96 well microplate.  The plates were covered and incubated at room 
temperature under static conditions for 1 day.   
A 2 % v/v emulsion stock solution made by diluting the generated capsules into LB 
medium.  The stock solution was then diluted to the desired level and incubated with the 
biofilms for 3 hrs.  Biofilms were washed with phosphate buffer saline (PBS) three times 
and viability was determined using an Alamar Blue assay.52  Modified LB medium 
without bacteria was used as a negative control.   
6.4.11. Biofilm-3T3 Fibroblast Cell Co-culture   
Co-culture was performed as previously described.50  Briefly, a total of 20,000 NIH 3T3 
(ATCC CRL-1658) cells were cultured in Dulbecco’s modified Eagle medium (DMEM; 
ATCC 30-2002) with 10 % bovine calf serum and 1% antibiotics at 37 °C in a humidified 
atmosphere of 5 % CO2. Cells were kept for 24 h to reach a confluent monolayer.  
Bacteria were inoculated and harvested as described above, and seeding solutions were 
made in buffered DMEM supplemented with glucose to reach an OD600 of 0.1.  Old 
medium was removed from 3T3 cells followed by addition of 100 μL of seeding solution.  
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The co-cultures were then stored in a box with damp paper towels at 37 °C overnight 
without shaking.   
Testing solutions at different concentrations were made by diluting capsules into DMEM 
prior to use.  Media was removed from co-culture, replaced with testing solutions, and 
incubated for 3 hrs at 37 °C.  Co-cultures were then analyzed using a LDH cytotoxicity 
assay to determine mammalian cell viability according the manufacturer’s instructions.53  
To determine bacteria viability in biofilms, the testing solutions were removed and co-
cultures were washed with PBS. Fresh PBS was then added to disperse remaining 
bacteria from biofilms in co-culture by sonication for 20 minutes and mixing with pipette. 
The solutions containing dispersed bacteria were then plated onto agar plates and colony 
forming units were counted after incubation at 37 °C overnight.  
6.4.12. Calculation of Cinnamaldehyde to Amine Ratio 
Diameter of SiO2 NP = 152 nm 
Total number of NPs in solution: 
𝑁𝑁𝑃 =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑁𝑃𝑠 𝑖𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑠𝑖𝑙𝑖𝑐𝑎 𝑁𝑃𝑠⁄
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑁𝑃
  
𝑁𝑁𝑃 =
(0.0144 𝑔)
(1.96 
𝑔
𝑐𝑚−3
)
⁄
1.84×10−15 𝑐𝑚−3
  
𝑁𝑁𝑃 = 4.00 × 10
12  
Moles of amine in solution: 
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 =
𝑁𝑁𝑃×𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑁𝑃×# 𝑜𝑓 𝑎𝑚𝑖𝑛𝑒 𝑔𝑟𝑜𝑢𝑝𝑠 𝑝𝑒𝑟 𝑛𝑚
2
6.02×1023 
𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙
  
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 =
(4.00×1012)×(72600 𝑛𝑚2)×(4.0
 𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑛𝑚2
)
(6.02×1023 
𝑎𝑚𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙
)
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𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑁𝐻2 = 1.9 × 10
−6 𝑚𝑜𝑙𝑒𝑠  
Moles of cinnamaldehyde (CA) in solution: 
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 =
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒 𝑖𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛×𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒
𝑀𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑐𝑖𝑛𝑛𝑎𝑚𝑎𝑙𝑑𝑒ℎ𝑦𝑑𝑒
  
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 =
(0.0150 𝑚𝐿)×(1.05 
𝑔
𝑚𝐿
)
132.16 
𝑔
 𝑚𝑜𝑙
  
𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝐶𝐴 = 1.20 × 10−4 𝑚𝑜𝑙𝑒𝑠  
Ratio of CA to NH2: 
62 
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